000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1511|2891|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|Risperídón||1511||1511|2891 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|6669|9891|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6669||6669|9891 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|44893|57759|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|Epóetín||44893||44893|57759 000055|B03XA0103|NeoRecormon|sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003|30.06.2009|R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|129541|163146|lyfsjukr|||00|1|0|60|Icepharma hf|Roche|Epóetín||129541||129541|163146 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|67234|85574|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|Epóetín||67234||67234|85574 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|11347|16239|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||11347||11347|16239 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|1708|3158|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||1708||1708|3158 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|3940|6187|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||3940||3940|6187 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|33761|44217|lyfalmen|||00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||33761||33761|44217 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|43906|56848|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||43906||43906|56848 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|22089|29686|lyfalmen|V0813|29137|00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||22089||22089|29686 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|9699|14002|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||9699||9699|14002 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6467|9259|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|Atosíban||6467||6467|9259 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|8309|15999|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||8309||8309|15999 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|17782|24006|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|Atosíban||17782||17782|24006 000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1729|3187|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1729||1729|3187 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|22129|29736|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||22129||22129|29736 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5878|8416|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Elektrólýtar||5878||5878|8416 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|43896|56835|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|Follitrópín beta||43896||43896|56835 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5831|8753|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|Rizatriptan||5831||5831|8753 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3114 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3483|5567|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3483|5567 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|30589|40268|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||30589||30589|40268 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2142|3747|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||2142||2142|3747 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5682|8551|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||5682||5682|8551 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4487|6929|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|Tópíramat||4487||4487|6929 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5868|8804|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5868||5868|8804 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|16355|22229|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Fitusambönd||16355||16355|22229 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|5009|7638|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||||5009|7638 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||2590||2590|3708 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4143|6463|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||4143||4143|6463 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|2|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|179904|225848|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|Interferón beta-1a||179904||179904|225848 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996|30.06.2009|R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|14688|20472|lyfalmen|||00|60|0|30|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||14688||14688|20472 000957|H01AC0101|Genotropin|sts|0| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|37270|48269|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||37270||37270|48269 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6913|9898|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|Ganirelix||6913||6913|9898 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1876|3386|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||1876||1876|3386 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12942|18298|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12942||12942|18298 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|24766|33019|lyfalmen|||00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||24766||24766|33019 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2504|4238|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|Metóprólól||2504||2504|4238 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|12861|18197|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||12861||12861|18197 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|440109|549803|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||440109||440109|549803 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|5093|7752|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||5093||5093|7752 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|1177|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis hf|Simvastatín||248||248|1177 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|35501|46066|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|Ganirelix||35501||35501|46066 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis hf|Simvastatín||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|Simvastatín||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|V0362|2265|00|98|0|65|Actavis Group hf|Actavis hf|Simvastatín||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3035|00|98|0|131|Actavis Group hf|Actavis hf|Simvastatín||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|7287|10729|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||7287||7287|10729 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4794|7346|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4794||4794|7346 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4173 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|29279|38320|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|Blöndur||29279||29279|38320 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|14380|20088|lyfalmen|V0011|19504|00|25|0|5|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||14380||14380|20088 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|39680|51269|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|Blöndur||39680||39680|51269 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26926|35390|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|Blöndur||26926||26926|35390 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7562|10827|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|Albúmín||7562||7562|10827 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|12077|16903|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|Albúmín||12077||12077|16903 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Vistor hf|Bayer A/S|Acetýlsalicýlsýra||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1417|2029|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1417||1417|2029 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4251|6609|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|Brinzólamíð||4251||4251|6609 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1122|2363|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1122||1122|2363 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|86880|110033|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín, lamívúdín og abacavír||86880||86880|110033 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4789|7339|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|Capsaicin||4789||4789|7339 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5475|8270|lyfalmen|V0793|8270|00|60|0|24|Actavis Group hf|Actavis hf|Risperídón||5475||5475|8270 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9840|14194|lyfalmen|V0456|14068|43|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||9840||9840|14194 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4049|6335|lyfalmen|V0084|6335|00|28|0|19|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4049||4049|6335 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7913|11579|lyfalmen|||0|56|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7913||7913|11579 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1479|2847|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1479||1479|2847 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5540|8358|lyfalmen|V0085|8238|00|28|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5540||5540|8358 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|5073|7725|lyfalmen|||00|100|0|27|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5073||5073|7725 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23381|30977|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|Blöndur||23381||23381|30977 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6771|10029|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6771||6771|10029 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20912|27903|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|Blöndur||20912||20912|27903 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34219|44470|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|Blöndur||34219||34219|44470 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13929|19527|lyfalmen|V0087|19527|00|100|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13929||13929|19527 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8835|12830|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8835||8835|12830 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|4269|6634|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|Insúlín aspart||4269||4269|6634 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19745|26768|lyfalmen|V0089|26377|00|100|0|133|Vistor hf|AstraZeneca A/S DK|Esómeprazól||19745||19745|26768 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001|30.06.2009|R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4377|6780|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||4377||4377|6780 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001|30.06.2009|R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7157|10553|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||7157||7157|10553 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7782|11401|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|Kalcípótríól||7782||7782|11401 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4529|6986|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|Kalcípótríól||4529||4529|6986 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|18813|25607|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|Montelúkast||18813||18813|25607 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|108218|136599|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||108218||108218|136599 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|54360|69546|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||54360||54360|69546 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|31160|40662|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||31160||31160|40662 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2906|4784|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||2906|4784 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1532|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|Enalapríl||510||510|1532 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2906|4784|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||2906||2906|4784 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Lóratadín||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Lóratadín||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3662|lyfalmen|V0984|3662|00|100|0|100|Actavis Group hf|Actavis hf|Lóratadín||2079||2079|3662 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|216528|271445|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||216528||216528|271445 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|3143|5439|vetorma|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||3143|5439 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1497|2872|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|Tímólól||1497||1497|2872 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|31841|41510|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||31841||31841|41510 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|69588|88822|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|Follitrópín alfa||69588||69588|88822 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|15548|16514|lyfalmen|V0193|16514|00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||11550||11550|16514 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|14694|20479|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|Levetíracetam||14694||14694|20479 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|304513|380986|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||304513||304513|380986 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|19874|26928|lyfalmen|V1710|26927|00|100|0|25|Vistor hf|U.C.B|Levetíracetam||19874||19874|26928 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|38615|50261|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Levetíracetam||38615||38615|50261 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|9352|13532|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||9352||9352|13532 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|13953|19556|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||13953||13953|19556 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|20510|27402|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|Darbepóetín alfa||20510||20510|27402 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|30555|39908|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|Darbepóetín alfa||30555||30555|39908 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|31820|41483|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|Darbepóetín alfa||31820||31820|41483 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|47042|60435|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|Darbepóetín alfa||47042||47042|60435 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|61631|78598|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|Darbepóetín alfa||61631||61631|78598 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|76012|96502|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|Darbepóetín alfa||76012||76012|96502 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|218536|273945|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||218536||218536|273945 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8575|12477|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8575||8575|12477 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|91286|115519|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|Darbepóetín alfa||91286||91286|115519 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7836|11474|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7836||7836|11474 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|120364|151721|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|Darbepóetín alfa||120364||120364|151721 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|68963|88044|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|Sirolimus||68963||68963|88044 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|148519|186774|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|Darbepóetín alfa||148519||148519|186774 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|222024|278287|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|Darbepóetín alfa||222024||222024|278287 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|111061|140138|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||111061||111061|140138 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4546|7010|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||4546||4546|7010 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3906|6141|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Mísóprostól||3906||3906|6141 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|15259|21182|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||15259||15259|21182 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|6990|10326|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||6990||6990|10326 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|23370|31281|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||||23370|31281 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|965|2150|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||965||965|2150 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1170|2428|lyfalmen|V0931|2428|00|28|0|28|Actavis Group hf|Actavis hf|Sertralín||1170||1170|2428 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|704|1796|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|Díklófenak||704||704|1796 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4068|6361|lyfalmen|V0933|6361|00|98|0|98|Actavis Group hf|Actavis hf|Sertralín||4068||4068|6361 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|103977|131319|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|Lopinavír||103977||103977|131319 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2354|4035|lyfalmen|V0608|2123|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2354||2354|4035 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|36669|47520|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||36669||36669|47520 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8758|12725|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8758||8758|12725 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4494|6939|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4494||4494|6939 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|655|1729|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||655||655|1729 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1172|2431|lyfalmen|||10|30|0|15|Vistor hf|Meda AB|Flúrazepam||1172||1172|2431 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6844|10128|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||6844||6844|10128 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|6558|9740|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6558||6558|9740 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|9128|13228|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9128||9128|13228 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|830|1967|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Deslóratadín||830||830|1967 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6559|9741|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|Mirtazapín||6559||6559|9741 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|24619|32518|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||24619||24619|32518 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1833|3328|lyfalmen|V1901|3326|00|30|0|30|Vistor hf|Schering-Plough|Deslóratadín||1833||1833|3328 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|9135|13237|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9135||9135|13237 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|5125|7795|lyfalmen|V1902|7795|00|100|0|100|Vistor hf|Schering-Plough|Deslóratadín||5125||5125|7795 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|5054|9798|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||5054||5054|9798 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3593|5716|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |Tramadól||3593||3593|5716 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|683|1767|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|Ísósorbíð dínítrat||683||683|1767 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3530|5631|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3530||3530|5631 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4792|7343|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |Tramadól||4792||4792|7343 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|36345|47117|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|Tegafur||36345||36345|47117 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6769|10026|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |Tramadól||6769||6769|10026 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|9009|13066|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |Tramadól||9009||9009|13066 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2172|3788|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2172||2172|3788 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|60575|77283|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|Tegafur||60575||60575|77283 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|72691|92368|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|Tegafur||72691||72691|92368 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|48461|62201|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|Tegafur||48461||48461|62201 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4469|6905|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |Glímepíríð||4469||4469|6905 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|40800|52664|lyfsjukr|||00|1|0|4|MedFarm ehf|E. Merck AB|Sómatrópín||40800||40800|52664 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2126|3725|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|Metrónídazól||2126||2126|3725 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2815|4660|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2815||2815|4660 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5273|7996|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5273||5273|7996 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|Cítalópram||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|Cítalópram||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|Cítalópram||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|Cítalópram||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1269|2562|lyfalmen|V0923|2562|00|28|0|28|Actavis Group hf|Actavis hf|Cítalópram||1269||1269|2562 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1699 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|47292|60746|lyfsjukr|||00|5|0|7|Vistor hf|Biovitrum AB (publ)|Anakinra||47292||47292|60746 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5|Actavis Group hf|Actavis hf|Dextrómetorfan||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|182069|228543|lyfsjukr|||00|19|0|28|Vistor hf|Biovitrum AB (publ)|Anakinra||182069||182069|228543 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|204004|255852|lyfsjukr|||00|5|0|20|MedFarm ehf|E. Merck AB|Sómatrópín||204004||204004|255852 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10438|15005|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10438||10438|15005 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|12047|16866|lyfsjukr|||00|1000|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||12047||12047|16866 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|22438|29803|lyfsjukr|||00|2000|0|7|Actavis Group hf|Actavis Group hf|Metrónídazól||22438||22438|29803 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9741|7942|lyfalmen|V0714|6450|0|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5233||5233|7942 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12760|10554|lyfalmen|V0715|8079|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||7158||7158|10554 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|718|1815|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||718||718|1815 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|76275|96830|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|Omalizúmab||76275||76275|96830 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5993|8580|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||5993||5993|8580 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|425|1417|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|Metrónídazól||425||425|1417 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|726|1826|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|Metrónídazól||726||726|1826 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1374|2705|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|Metrónídazól||1374||1374|2705 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1895|3412|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1895||1895|3412 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2563|4318|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2563|4318 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|11345|7540|lyfalmen|V0437|7230|00|90|0|90|Vistor hf|Yamanouchi Europe|Tamsúlósín||4937||4937|7540 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|||10|30|0|4|Actavis Group hf|Actavis hf|Díkloxacillín||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|Díkloxacillín||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis hf|Díkloxacillín||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|25725|34213|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||25725||25725|34213 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|46597|60198|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||46597||46597|60198 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|3074|5012|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3074||3074|5012 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Napp|Joð/pólývídón||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1246|2531|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1246||1246|2531 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|64249|82175|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|Góserelín||64249||64249|82175 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|41806|54233|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|Metýlamínólevúlínat||41806||41806|54233 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1644|3071|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1644||1644|3071 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|32708|17945|lyfalmen|V0815|16672|00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||12659||12659|17945 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5867|8802|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|Alendrónsýra||5867||5867|8802 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|41598|53974|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||41598||41598|53974 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1128|2371|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1128||1128|2371 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|16271|22442|lyfalmen|V0718|8018|00|12|0|84|Icepharma hf|M.S.D.|Alendrónsýra||16271||16271|22442 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|6924|10237|lyfalmen|V2110|10237|00|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||6924||6924|10237 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7297|10743|lyfalmen|V0985|10743|0|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||7297||7297|10743 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4273|6639|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4273||4273|6639 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1767|3238|lyfalmen|||00|30|0|6|Icepharma hf|Servier|Glíklazíð||1767||1767|3238 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|3081|5021|lyfalmen|||00|60|0|11|Icepharma hf|Servier|Glíklazíð||3081||3081|5021 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|8180|11941|lyfalmen|||00|180|0|34|Icepharma hf|Servier|Glíklazíð||8180||8180|11941 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4495|6940|lyfalmen|||00|90|0|17|Icepharma hf|Servier|Glíklazíð||4495||4495|6940 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6805|10075|lyfalmen|||00|180|0|90|Icepharma hf|Servier|Estradíól||6805||6805|10075 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|2633|4413|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2633||2633|4413 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|4867|6968|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||4867||4867|6968 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|74339|94420|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||74339||74339|94420 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|38163|49380|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|Cetrorelix||38163||38163|49380 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|38163|49380|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||38163||38163|49380 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|8057|11774|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8057||8057|11774 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|3486|5571|lyfalmen|V0939|5524|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3486||3486|5571 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|18285|31643|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||18285||18285|31643 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7101|10477|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7101||7101|10477 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|82883|105057|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||82883||82883|105057 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|11690|16704|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11690||11690|16704 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6264|9341|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6264||6264|9341 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3476|5557|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3476||3476|5557 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3300|5319|lyfalmen|||59|8|0|2|Icepharma hf|Roche|Meflókvín||3300||3300|5319 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|976|2165|lyfalmen|||00|1|0|1|Icepharma hf|Eli Lilly Nederland -|Olanzapín||976||976|2165 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|11375|16277|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||11375||11375|16277 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|23893|31932|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||23893||23893|31932 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4070|6364|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan||4070||4070|6364 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7657|11231|lyfalmen|||00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7657||7657|11231 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10445|13480|lyfalmen|V1110|10792|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan||9314||9314|13480 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|15556|21552|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||15556||15556|21552 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5189|7882|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan||5189||5189|7882 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|14196|18965|lyfalmen|V1111|15244|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan||13478||13478|18965 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|94232|119186|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||94232||94232|119186 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6396|9520|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||6396||6396|9520 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|35289|45802|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||35289||35289|45802 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|136899|172307|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||136899||136899|172307 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|6204|9260|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||6204||6204|9260 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|188597|236671|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||188597||188597|236671 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|95470|120728|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||95470||95470|120728 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|1249|2535|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||1249||1249|2535 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9252|13396|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9252||9252|13396 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|40728|52574|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||40728||40728|52574 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|70025|89049|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||70025||70025|89049 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2619|4394|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Flúkloxacillín||||2619|4394 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2616|4390|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2616||2616|4390 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9752|18747|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||9752||9752|18747 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10353|14890|lyfalmen|V0391|14619|00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10353||10353|14890 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|15370|21321|lyfalmen|V2001|20937|00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||15370||15370|21321 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|38773|50457|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||38773||38773|50457 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|17177|23570|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||17177||17177|23570 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|16174|22322|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan||16174||16174|22322 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4163|6490|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||4163||4163|6490 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|792|1915|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||792||792|1915 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|31047|40838|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|Sevelamer||31047||31047|40838 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|26770|51164|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||26770||26770|51164 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13242|18671|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||13242||13242|18671 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1978|3525|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1978||1978|3525 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6237|9304|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||6237||6237|9304 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19845|26892|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||19845||19845|26892 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|6398|9523|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||6398||6398|9523 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8279|12075|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||8279||8279|12075 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|28977|38261|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||28977||28977|38261 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|165126|207449|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|Prótein C||165126||165126|207449 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|291688|365019|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|Prótein C||291688||291688|365019 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2332|4005|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2332||2332|4005 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2915|4796|lyfalmen|||00|3|0|30|Vistor hf|Allergan|Bimatóprost||2915||2915|4796 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|165303|207670|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||165303||165303|207670 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|254403|318599|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||254403||254403|318599 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|221178|277234|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||221178||221178|277234 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|144324|181551|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||144324||144324|181551 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|363604|454554|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||363604||363604|454554 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3916|6155|lyfalmen|V0988|6049|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tímólól í blöndum||3916||3916|6155 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|7852|11242|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||7852||7852|11242 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|133494|168068|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||133494||133494|168068 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|28468|37310|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Sevóflúran||28468||28468|37310 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer Animal Health GmbH||||||3769 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7613|11172|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||7613||7613|11172 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5484|8282|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5484||5484|8282 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3323|5350|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan||3323||3323|5350 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5484|8282|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5484||5484|8282 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|10064|14397|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|Paracetamól||10064||10064|14397 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23777|31787|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||23777||23777|31787 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|10688|15345|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|Mometasón||10688||10688|15345 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10573|15188|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan||10573||10573|15188 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2798|4006|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2798||2798|4006 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2531|4275|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|Candesartan||2531||2531|4275 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8476|12343|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||8476||8476|12343 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|25739|34230|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||25739||25739|34230 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4500|6947|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4500||4500|6947 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0|Icepharma hf|Baxter|||||| 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2405|4104|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2405||2405|4104 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1358|2683|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Ólópatadín||1358||1358|2683 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|176167|221195|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||176167||176167|221195 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|24605|32501|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|Nituroxíð||24605||24605|32501 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|44389|57132|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||44389||44389|57132 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|732|1834|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformín||732||732|1834 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3919|6159|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3919||3919|6159 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|26719|35133|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||26719||26719|35133 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|33400|43451|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||33400||33400|43451 008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|378|1353|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||378||378|1353 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|7454|10956|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|Rizatriptan||7454||7454|10956 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|102299|129230|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|Peginterferón alfa 2b||102299||102299|129230 008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1198|2466|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1198||1198|2466 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|205664|257919|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|Peginterferón alfa 2b||205664||205664|257919 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|149139|187546|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|Peginterferón alfa 2b||149139||149139|187546 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|219525|275176|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|Peginterferón alfa 2b||219525||219525|275176 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|256273|320927|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|Peginterferón alfa 2b||256273||256273|320927 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2247|3890|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2247||2247|3890 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1285|2584|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1285||1285|2584 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|307|1257|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||307||307|1257 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|35187|45675|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||35187||35187|45675 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|27475|36074|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||27475||27475|36074 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|504|1524|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||504||504|1524 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|34433|44737|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||34433||34433|44737 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8578|12481|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|Candesartan||8578||8578|12481 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1301|2606|lyfalmen|V0733|2606|00|20|0|7|Actavis Group hf|Actavis hf|Tramadól||1301||1301|2606 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2719|4530|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Candesartan||2719||2719|4530 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1503|2880|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1503||1503|2880 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8653|12583|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Candesartan||8653||8653|12583 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|5094|7753|lyfalmen|V0734|7753|00|100|0|33|Actavis Group hf|Actavis hf|Tramadól||5094||5094|7753 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|7818|11450|lyfalmen|V0736|11450|00|100|0|50|Actavis Group hf|Actavis hf|Tramadól||7818||7818|11450 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|10294|14810|lyfalmen|V0738|14810|00|100|0|67|Actavis Group hf|Actavis hf|Tramadól||10294||10294|14810 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|228802|286726|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|Thýrótrópín||228802||228802|286726 008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|378|1353|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||378||378|1353 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|861|2009|lyfalmen|V0431|2009|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||861||861|2009 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|728|1828|lyfalmen|V0430|1828|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||728||728|1828 008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1198|2466|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1198||1198|2466 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5236|9061|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||5236||5236|9061 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|12062|23147|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||12062||12062|23147 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4973|7589|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4973||4973|7589 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3196|5178|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3196||3196|5178 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|145365|182847|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||145365||145365|182847 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|151528|190520|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||151528||151528|190520 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2682|4641|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2682||2682|4641 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3404|5460|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3404||3404|5460 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3323|5350|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3323||3323|5350 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2531|4275|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2531||2531|4275 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6686|9914|lyfalmen|V1350|9732|00|4|0|8|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6686|9914 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|950|2130|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||950||950|2130 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13171|18583|lyfalmen|V1351|18254|00|8|0|16|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13171|18583 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5743|8634|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5743||5743|8634 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|17826|24378|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||17826||17826|24378 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|8126|11868|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|Parekoxíb||8126||8126|11868 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|15425|21389|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|Parekoxíb||15425||15425|21389 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|67401|85782|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||67401||67401|85782 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0|Icepharma hf|Fresenius Kabi||||||1754 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6138|9170|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6138||6138|9170 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1506|2884|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|Estradíól||1506||1506|2884 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1619|3037|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Estradíól||1619||1619|3037 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1907|3428|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|Estradíól||1907||1907|3428 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2194|3818|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|Estradíól||2194||2194|3818 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|269236|337066|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||269236||269236|337066 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6296|9384|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6296||6296|9384 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003|30.06.2009|R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|10207|14692|lyfalmen|||00|55|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10207||10207|14692 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|77772|98694|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||77772||77772|98694 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10571|15186|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||10571||10571|15186 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|45693|58755|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|Epóetín||45693||45693|58755 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|930|2102|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||930||930|2102 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7273|10710|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||7273||7273|10710 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7139|10528|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7139||7139|10528 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8461|12322|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8461||8461|12322 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|607|1664|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|Mirtazapín||607||607|1664 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7703|11294|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7703||7703|11294 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8492|12364|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8492||8492|12364 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6533|9706|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||6533||6533|9706 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2578|4339|lyfalmen|V1151|3088|00|30|0|15|Vistor hf|N.V. Organon|Mirtazapín||2578||2578|4339 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4575|7049|lyfalmen|V1152|4489|00|30|0|30|Vistor hf|N.V. Organon|Mirtazapín||4575||4575|7049 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|9770|14099|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|Mirtazapín||9770||9770|14099 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|188265|236257|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||188265||188265|236257 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|4984|7604|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|Follitrópín alfa||4984||4984|7604 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1332|2648|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||1332||1332|2648 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|51205|65935|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|Follitrópín alfa||51205||51205|65935 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|30725|40438|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||30725||30725|40438 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|268458|336098|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|Valgancíklóvír||268458||268458|336098 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|464050|579610|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||464050||464050|579610 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|179344|225151|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||179344||179344|225151 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|9061|12973|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|Ertapenem||9061||9061|12973 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|14200|19864|lyfalmen|V1153|13826|00|96|0|96|Vistor hf|N.V. Organon|Mirtazapín||14200||14200|19864 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|21513|28969|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|Mirtazapín||21513||21513|28969 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002|30.06.2009|R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|9153|13261|lyfalmen|||00|30|0|15|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||9153||9153|13261 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002|30.06.2009|R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|14950|20798|lyfalmen|||00|50|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||14950||14950|20798 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|25656|34127|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||25656||25656|34127 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|4297|6672|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4297||4297|6672 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|9887|14258|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||9887||9887|14258 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|13880|19466|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13880||13880|19466 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|81903|156184|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||81903||81903|156184 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|6970|10299|lyfalmen|||00|60|0|32|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6970||6970|10299 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|13419|18574|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|Elektrólýtar||13419||13419|18574 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9244|13235|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Amínósýrur||9244||9244|13235 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1472|2838|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|Levófloxacín||1472||1472|2838 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5325|8067|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||5325||5325|8067 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7109|10178|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Kolvetni||7109||7109|10178 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|13037|18099|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Kolvetni||13037||13037|18099 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4962|7104|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||4962||4962|7104 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2843|4070|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||2843||2843|4070 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|8108|11843|lyfalmen|||00|9|0|90|Vistor hf|Allergan|Bimatóprost||8108||8108|11843 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|13037|18099|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Elektrólýtar||13037||13037|18099 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7156|10246|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Elektrólýtar||7156||7156|10246 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4771|6831|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||4771||4771|6831 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|13808|19376|lyfalmen|V1080|19376|00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||13808||13808|19376 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2648|3791|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2648||2648|3791 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|472227|589790|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||472227||472227|589790 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|442108|552292|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||442108||442108|552292 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|693548|865335|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||693548||693548|865335 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|923037|1151049|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||923037||923037|1151049 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2672|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|Ómeprazól||1350||1350|2672 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6037|7550|lyfalmen|V2171|7550|10|100|0|100|Actavis Group hf|Actavis hf|Ómeprazól||4944||4944|7550 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3384|4259|lyfalmen|V2170|4259|10|56|0|56|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4259 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|51738|66281|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|Bleómýcín||51738||51738|66281 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2976|4261|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|Kloxacillín||2976||2976|4261 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|3133|5092|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|Lansóprazól||3133||3133|5092 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|24598|32809|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24598||24598|32809 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|24598|32809|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24598||24598|32809 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|41167|53438|lyfalmen|V1702|53437|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||41167||41167|53438 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|41167|53438|lyfalmen|V1703|53437|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||41167||41167|53438 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|19064|25920|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|Búdesóníð||19064||19064|25920 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6529|9701|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Etoríkoxíb||6529||6529|9701 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6529|9701|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|Etoríkoxíb||6529||6529|9701 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|22514|30215|lyfalmen|V2172|30215|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||22514||22514|30215 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|Lósartan||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|13637|19163|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||13637||13637|19163 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|5469|lyfalmen|V0197|5469|00|98|0|98|Actavis Group hf|Actavis hf|Lósartan||3411||3411|5469 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8551|12445|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8551||8551|12445 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|12895|18239|lyfalmen|||00|12|0|6|Vistor hf|Bayer AG-|Vardenafíl||12895||12895|18239 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7069|10433|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7069||7069|10433 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8304|11889|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|Mannitól||8304||8304|11889 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2677|3833|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||2677||2677|3833 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6529|9701|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|Etoríkoxíb||6529||6529|9701 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9235|13373|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9235||9235|13373 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1688|3331|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1688||1688|3331 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|5354|7666|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||5354||5354|7666 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1461|2823|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1461||1461|2823 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|117758|148476|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|Ribavirin||117758||117758|148476 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|11426|16346|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||11426||11426|16346 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2003|3559|lyfalmen|V0935|3559|00|28|0|56|Actavis Group hf|Actavis hf|Sertralín||2003||2003|3559 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|7008|10351|lyfalmen|V0937|10351|00|98|0|196|Actavis Group hf|Actavis hf|Sertralín||7008||7008|10351 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4364|6248|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4364||4364|6248 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3963|5674|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3963||3963|5674 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8863|12868|lyfalmen|||00|28|0|14|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||8863|12868 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4955|7565|lyfalmen|||00|28|0|37|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||4955||4955|7565 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|17055|23418|lyfalmen|||00|98|0|131|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||17055||17055|23418 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|50009|64129|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|Efavirenz||50009||50009|64129 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|12265|17455|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||12265||12265|17455 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1380|2713|lyfalmen|||00|20|0|36|Vistor hf|Meda AB|Azelastínum||1380||1380|2713 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6663|9882|lyfalmen|||00|4|0|4|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6663||6663|9882 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5924|10252|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||5924||5924|10252 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|888|2045|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |Glímepíríð||888||888|2045 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10944|15692|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10944||10944|15692 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|27840|48179|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||27840||27840|48179 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|522974|652970|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Díbótermín alfa||522974||522974|652970 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4598|7080|lyfalmen|||00|4|0|2|Vistor hf|Bayer AG-|Vardenafíl||4598||4598|7080 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|5087|7744|lyfalmen|||00|4|0|4|Vistor hf|Bayer AG-|Vardenafíl||5087||5087|7744 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|14986|20843|lyfalmen|||00|12|0|12|Vistor hf|Bayer AG-|Vardenafíl||14986||14986|20843 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|6307|9399|lyfalmen|||00|4|0|8|Vistor hf|Bayer AG-|Vardenafíl||6307||6307|9399 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|18235|24888|lyfalmen|||00|12|0|24|Vistor hf|Bayer AG-|Vardenafíl||18235||18235|24888 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4381|6786|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4381||4381|6786 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6774|10033|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|Testósterón||6774||6774|10033 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6844|10128|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6844||6844|10128 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7505|14467|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7505||7505|14467 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|11169|15997|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||11169||11169|15997 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1946|3840|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1946||1946|3840 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|1323|2636|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|Lansóprazól||1323||1323|2636 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|24605|32501|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|Nituroxíð||24605||24605|32501 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|9704|13894|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||9704||9704|13894 013259|B02BD0901|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|34571|44908|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||34571||34571|44908 013270|B02BD0901|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|69147|87956|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||69147||69147|87956 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4929|9560|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4929||4929|9560 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11847|22738|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||11847||11847|22738 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1243|2453|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1243||1243|2453 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|199075|249716|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||199075||199075|249716 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|33179|43175|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||33179||33179|43175 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|132716|167099|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||132716||132716|167099 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|64631|82333|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||64631||64631|82333 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|20854|28148|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Ezetimíb||20854||20854|28148 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|188151|236115|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||188151||188151|236115 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf|Blöndur|||||1367 013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002|30.04.2009|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|6327|9426|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||6327||6327|9426 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1369|2698|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1369||1369|2698 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|506|1527|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||506||506|1527 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|50777|65085|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||50777||50777|65085 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|5210|7911|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5210||5210|7911 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|15739|21780|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15739||15739|21780 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2489 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7715|11310|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||7715||7715|11310 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5994|8975|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||5994||5994|8975 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2936|4825|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2936||2936|4825 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5142|7818|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||5142||5142|7818 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|230212|288481|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||230212||230212|288481 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|432028|539742|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||432028||432028|539742 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2911|4791|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2911||2911|4791 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|15867|21622|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15867||15867|21622 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|26026|34587|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|Levetíracetam||26026||26026|34587 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|63482|81220|lyfalmen|||AC|3|0|38|Icepharma hf|Eli Lilly Nederland -|Teriparatíð||63482||63482|81220 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|39880|51518|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||39880||39880|51518 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1401|2742|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1401||1401|2742 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24566|32452|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||24566||24566|32452 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|27051|35546|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|Blöndur||27051||27051|35546 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35402|45943|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||35402||35402|45943 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24566|32452|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||24566||24566|32452 014435|QM01AE03  |Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2543|5015|vetalmen|||00|45|0|0|Dýraheilsa ehf|Vetcare Ltd.|||||2543|5015 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|16851|23164|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||16851||16851|23164 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|91806|116166|lyfsjukr|||0|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|||||91806|116166 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|6320|12210|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6320||6320|12210 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|324725|406150|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|Enfúvirtíð||324725||324725|406150 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2675|4470|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |Oxýcódon||2675||2675|4470 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4729|7258|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|Candesartan||4729||4729|7258 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|16004|22110|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|Candesartan||16004||16004|22110 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|83704|106079|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|Fílgrastím||83704||83704|106079 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|129575|163188|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|Fílgrastím||129575||129575|163188 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|21424|28858|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|Everolímus||21424||21424|28858 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|64649|82673|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|Everolímus||64649||64649|82673 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|43033|55761|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|Everolímus||43033||43033|55761 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|703|1794|lyfalmen|||00|10|0|18|Vistor hf|Meda AB|Azelastínum||703||703|1794 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Mirtazapín||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|9546|13795|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||9546||9546|13795 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Mirtazapín||2563||2563|4318 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4586|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4586 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1210|2482|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|Estradíól||1210||1210|2482 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|11753|16790|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||11753||11753|16790 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|383638|479497|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||383638||383638|479497 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|101969|128819|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||101969||101969|128819 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6803|10072|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6803||6803|10072 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14993|20851|lyfalmen|V1732|20850|00|100|0|11|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14993||14993|20851 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6803|10072|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6803||6803|10072 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|16207|22363|lyfalmen|V1731|22363|00|100|0|33|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||16207||16207|22363 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|36501|47629|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||36501||36501|47629 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|88750|112361|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||88750||88750|112361 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|88750|112361|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||88750||88750|112361 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|88750|112361|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||88750||88750|112361 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6803|10072|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6803||6803|10072 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14834|20653|lyfalmen|V1730|20653|00|100|0|22|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14834||14834|20653 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|88750|112361|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||88750||88750|112361 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|30817|40552|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||30817||30817|40552 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|53596|68912|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||53596||53596|68912 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1013|2215|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Cýklópentólat||1013||1013|2215 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3538|6123|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3538||3538|6123 015833|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|4105|5877|lyfsjukr|||00|750|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||4105|5877 015844|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|7853|11244|lyfsjukr|||00|1500|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||7853|11244 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4971|8603|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||4971||4971|8603 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3156|5462|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3156||3156|5462 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3957|6848|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||3957||3957|6848 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|5042|7683|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||5042||5042|7683 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4433|7672|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||4433||4433|7672 015912|D11AX1401|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AX14|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2228|3864|lyfalmen|||0|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||||2228|3864 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2503|4237|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||2503||2503|4237 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1672|3109|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|Morfín||1672||1672|3109 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3538|6123|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3538||3538|6123 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|100|GBP|1609|3024|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1609||1609|3024 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|17197|23595|lyfalmen|||00|90|0|180|Icepharma hf|Servier|Perindópríl||17197||17197|23595 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|5392|8158|lyfalmen|||00|6|0|6|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||5392||5392|8158 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|5784|8690|lyfalmen|||00|30|0|60|Icepharma hf|Servier|Perindópríl||5784||5784|8690 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|7634|11200|lyfalmen|||00|9|0|9|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||7634||7634|11200 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13523|19021|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||13523||13523|19021 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1242|2526|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|Petidín||1242||1242|2526 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|20260|27409|lyfalmen|||00|100|0|200|Vistor hf|AstraZeneca A/S DK|||20260||20260|27409 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1317|2628|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|Petidín||1317||1317|2628 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|2784|4618|lyfalmen|||00|3|0|3|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||2784||2784|4618 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8660|12592|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||8660||8660|12592 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|8088|11816|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|Risperídón||8088||8088|11816 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4844|7414|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||4844||4844|7414 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3649|5792|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3649||3649|5792 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7751|11359|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7751||7751|11359 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|5030|7666|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|Chóríógónadótrópín alfa||5030||5030|7666 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11800|16854|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11800||11800|16854 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2451|4167|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2451||2451|4167 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16367|22562|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16367||16367|22562 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|12392|17613|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|Ísradipín||12392||12392|17613 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4556|7023|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|Risperídón||4556||4556|7023 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|5149|7372|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||5149||5149|7372 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6518|9332|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||6518||6518|9332 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|18929|25434|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||18929||18929|25434 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|156078|196185|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||156078||156078|196185 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9466|13553|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||9466||9466|13553 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2904|4781|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2904||2904|4781 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8752|12531|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||8752||8752|12531 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|29672|38809|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||29672||29672|38809 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|249178|312094|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||249178||249178|312094 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|87390|110668|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||87390||87390|110668 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|20686|27939|lyfalmen|V1701|27425|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20686||20686|27939 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7646 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|41372|53693|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||41372||41372|53693 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2233|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|266746|333966|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|Epóetín||266746||266746|333966 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|233197|292198|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||233197||233197|292198 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2992|4901|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|Metformín||2992||2992|4901 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|9121|13218|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9121||9121|13218 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|77733|98645|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||77733||77733|98645 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|4140|6459|lyfalmen|V0789|5467|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||4140||4140|6459 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|7549|11085|lyfalmen|V0713|11085|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||7549||7549|11085 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|71636|91372|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|Cinacalcet||71636||71636|91372 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|105888|134016|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|Cinacalcet||105888||105888|134016 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|34458|45085|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|Cinacalcet||34458||34458|45085 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|57457|73719|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|Follitrópín alfa||57457||57457|73719 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|21978|29548|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|Follitrópín alfa||21978||21978|29548 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|32964|43225|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||32964||32964|43225 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|2452|4168|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|Lansóprazól||2452||2452|4168 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|4759|7299|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|Lansóprazól||4759||4759|7299 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|9267|13416|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|Lansóprazól||9267||9267|13416 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|9336|13510|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|Lansóprazól||9336||9336|13510 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|44770|57606|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||44770||44770|57606 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|16357|22549|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|Lansóprazól||16357||16357|22549 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3864|6084|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |Búprenorfín||3864||3864|6084 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|20928|40036|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||20928||20928|40036 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36210|46949|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|Blöndur||36210||36210|46949 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1704|3153|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Medroxýprógesterón||1704||1704|3153 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1724|3180|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1724||1724|3180 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|320747|401198|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|Cýtarabín||320747||320747|401198 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7721|11318|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|Diltíazem||7721||7721|11318 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|176836|222028|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||176836||176836|222028 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|50568|64825|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||50568||50568|64825 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|37426|48463|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|Blöndur||37426||37426|48463 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1605|3018|lyfalmen|V0221|3018|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1605||1605|3018 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|152421|191632|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||152421||152421|191632 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|56434|72445|lyfalmen|||00|28|0|0|Icepharma hf|Roche|||56434||56434|72445 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|168444|211898|lyfalmen|||00|84|0|0|Icepharma hf|Roche|||168444||168444|211898 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6839|10121|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |Búprenorfín||6839||6839|10121 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|4134|6450|lyfalmen|V0714|6450|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Gabapentín||4134||4134|6450 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|12772|18086|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |Búprenorfín||12772||12772|18086 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|3006|4920|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||3006||3006|4920 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|12711|17693|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|Aprepitant||12711||12711|17693 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3133|5092|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|Prednisón||3133||3133|5092 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|8060|11778|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |Betahistín||8060||8060|11778 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7469|14399|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7469||7469|14399 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|38801|50492|lyfalmen|V1371|50492|00|84|0|84|Vistor hf|Janssen-Cilag AB|Galantamín||38801||38801|50492 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|12054|17192|lyfalmen|V1370|17192|00|28|0|14|Vistor hf|Janssen-Cilag AB|Galantamín||12054||12054|17192 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12499|17746|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||12499||12499|17746 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|48479|62541|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|Galantamín||48479||48479|62541 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12499|17746|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||12499||12499|17746 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2704|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||1373||1373|2704 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|6545|9722|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||6545||6545|9722 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3013|4929|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3013||3013|4929 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|4450|6879|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|||4450||4450|6879 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|66357|84482|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||66357||66357|84482 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|13936|19535|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|||13936||13936|19535 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|9788|14123|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|||9788||9788|14123 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3540|5644|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3540||3540|5644 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3866|6087|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3866||3866|6087 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|11495|16440|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|||11495||11495|16440 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17799|24027|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||17799||17799|24027 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|88013|111444|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||88013||88013|111444 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3742|5918|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3742||3742|5918 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|35851|46502|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||35851||35851|46502 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|9217|13348|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|Sólífenacín||9217||9217|13348 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|15254|20859|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|Ceftríaxón||15254||15254|20859 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1628|3050|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Valsartan||1628||1628|3050 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|22585|30303|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|Sólífenacín||22585||22585|30303 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3257|5260|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|Valsartan||3257||3257|5260 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1238|2520|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |Prednisólón||1238||1238|2520 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7271|10707|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Sólífenacín||7271||7271|10707 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|18388|25078|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Sólífenacín||18388||18388|25078 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|41670|54064|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||41670||41670|54064 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|147008|184892|lyfsjukr|||00|28|0|0|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||||147008|184892 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|53460|68186|lyfalmen|V0375|42525|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||53013||53013|68186 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|58031|73597|lyfalmen|V0376|47463|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||57359||57359|73597 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|16271|22442|lyfalmen|V0718|8018|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|Alendrónsýra||16271||16271|22442 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3471|5551|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3471||3471|5551 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|10739|15414|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||10739||10739|15414 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|64028|81582|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Fosamprenavír||64028||64028|81582 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|664|1741|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||664||664|1741 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1248|2463|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1248||1248|2463 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|14351|20052|lyfalmen|V1052|15141|00|5|0|62|Vistor hf|Janssen-Cilag AB|Fentanýl||14351||14351|20052 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16390|22591|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16390||16390|22591 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16390|22591|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||16390||16390|22591 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|16067|21424|lyfalmen|V1372|21421|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15453||15453|21424 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9309|13473|lyfalmen|V1051|11060|00|5|0|42|Vistor hf|Janssen-Cilag AB|Fentanýl||9309||9309|13473 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|8195|11961|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||8195||8195|11961 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|5031|7668|lyfalmen|V1050|6148|00|5|0|21|Vistor hf|Janssen-Cilag AB|Fentanýl||5031||5031|7668 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|16087|22213|lyfalmen|V1053|17957|00|5|0|83|Vistor hf|Janssen-Cilag AB|Fentanýl||16087||16087|22213 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|63447|80859|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||63447||63447|80859 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|827201|1031733|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||827201||827201|1031733 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7608|11165|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7608||7608|11165 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|66206|84294|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||66206||66206|84294 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7608|11165|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7608||7608|11165 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|18722|25494|lyfalmen|||00|140|0|0|Icepharma hf|Eli Lilly Nederland -|||18722||18722|25494 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|667|1746|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||667||667|1746 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3999|6267|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||3999||3999|6267 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|9992|14400|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||9992||9992|14400 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5700|8576|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||5700||5700|8576 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|19031|25879|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||19031||19031|25879 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3999|6267|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||3999||3999|6267 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|13965|19571|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||13965||13965|19571 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6737|9646|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6737||6737|9646 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5700|8576|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5700||5700|8576 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|19031|25879|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||19031||19031|25879 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|697|1786|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||697||697|1786 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|33561|43651|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||33561||33561|43651 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|242249|303468|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||242249||242249|303468 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1019|2223|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1019||1019|2223 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|244026|305680|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Pemetrexed||244026||244026|305680 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13534|19035|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13534||13534|19035 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13534|19035|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13534||13534|19035 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|61970|79338|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|Follitrópín beta||61970||61970|79338 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13534|19035|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13534||13534|19035 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13534|19035|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13534||13534|19035 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13534|19035|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13534||13534|19035 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|874788|1090979|lyfsjukr|||02|6|0|9|Vistor hf|Biovitrum AB (publ)|Palifermín||874788||874788|1090979 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|423|1414|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||423||423|1414 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|72555|92198|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||72555||72555|92198 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1526|2911|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1526||1526|2911 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Ferrósúlfat||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020180|C03CC0101|Edecrin|sts|0| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|26861|35309|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||26861||26861|35309 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4961|7573|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4961||4961|7573 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|28289|37405|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||28289||28289|37405 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2655|4443|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2655||2655|4443 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|846|1988|lyfalmen|||00|7|0|3|Icepharma hf|Wyeth AB|Venlafaxín||846||846|1988 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|10906|15640|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Tamsúlósín||10906||10906|15640 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|59120|75789|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||59120||59120|75789 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4450|6879|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4450||4450|6879 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|100|DKK|4038|6320|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4038||4038|6320 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12866|18203|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12866||12866|18203 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|27412|36313|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||27412||27412|36313 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|807|1936|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||807||807|1936 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7702|11292|lyfalmen|||00|28|0|28|Icepharma hf|Servier|Strontíum ranelat||7702||7702|11292 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2354|4035|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2354||2354|4035 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4718|6422|lyfalmen|V0709|6422|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||4113||4113|6422 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|6876|10032|lyfalmen|V0710|10030|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||6773||6773|10032 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|13706|17410|lyfalmen|V0711|17410|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||12229||12229|17410 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3512|5524|lyfalmen|V0939|5524|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Escítalópram||3451||3451|5524 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|22595|30316|lyfalmen|||00|84|0|84|Icepharma hf|Servier|Strontíum ranelat||22595||22595|30316 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki||G03CA03|01.07.2004|31.05.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2051|3624|lyfalmen|||5|15|0|15|D.A.C. ehf|D.A.C. ehf|Estradíól||2051||2051|3624 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK||4392|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|Gabapentín||2617||2617|4392 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||| 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004|31.05.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7715|11310|lyfalmen|||0|120|0|30|D.A.C. ehf|D.A.C. ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7715||7715|11310 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2472|4278|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2472||2472|4278 020774|L04AB0101|Enbrel|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|213334|267468|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||213334||213334|267468 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996|30.06.2009|R|A|3|0|0|B|0|WLN|0|1|0|100|USD|2554|4306|lyfalmen|||00|28|0|10|Icepharma hf|Wyeth Lederle Nordiska|Venlafaxín||||2554|4306 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|3066|5001|lyfalmen|V0429|5001|00|3|0|5|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||3066||3066|5001 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006|31.05.2009|R|K|3|0|0|E|0|BIP|0|0|0|100|SEK|5510|8318|lyfalmen|||00|100|0|0|Vistor hf|BioPhausia AB|Acetýlcýstein||5510||5510|8318 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6713|9950|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|Montelúkast||6713||6713|9950 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2345|4023|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|Adapalen||2345||2345|4023 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|714|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3838|6049|lyfalmen|V0988|6049|06|2|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||3838||3838|6049 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|10010|12694|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|Quetíapín||8735||8735|12694 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004|31.05.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|11974|15545|lyfalmen|||00|60|0|20|D.A.C. ehf|D.A.C. ehf|Tópíramat||10836||10836|15545 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2233|lyfalmen|V0466|2233|00|12|0|12|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1026||1026|2233 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1436|lyfalmen|V0609|1424|00|30|0|15|Actavis Group hf|Actavis hf|Díklófenak||439||439|1436 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1131|2375|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Dexpantenól||1131||1131|2375 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004|31.05.2009|R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1705|3154|lyfalmen|||23|200|0|50|D.A.C. ehf|D.A.C. ehf|Terbútalín||1705||1705|3154 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|4318|3693|lyfalmen|V0931|2428|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Sertralín||2102||2102|3693 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|6737|5624|lyfalmen|V0935|3559|00|28|0|56|D.A.C. ehf|D.A.C. ehf|Sertralín||3525||3525|5624 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|16878|23198|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|Testósterón||16878||16878|23198 021278|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2009||R|K|3|0|0|*|0|DAC|0|0|0|100|DKK|3032|4955|lyfalmen|V1989|4955|0|2|0|25|D.A.C. ehf|D.A.C. ehf|Latanóprost||||3032|4955 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|7854|10743|lyfalmen|V0985|10743|0|30|0|30|D.A.C. ehf|D.A.C. ehf|Tíótrópíumbrómíð||7297||7297|10743 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|9583|13845|lyfalmen|V0993|13845|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||9583|13845 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|19163|26043|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|Montelúkast||19163||19163|26043 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|7321|10775|lyfalmen|V0992|10775|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||7321|10775 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5451|8238|lyfalmen|V0085|8238|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5451||5451|8238 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|XEU|20145|22866|lyfalmen|V0560|22866|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Bíkalútamíð||16611||16611|22866 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004|31.05.2009|R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1377|2709|lyfalmen|||24|120|0|38|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1377||1377|2709 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|13519|17543|lyfalmen|V0729|17543|0|100|0|20|D.A.C. ehf|D.A.C. ehf|Entakapón||12336||12336|17543 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6|Vistor hf|Boehringer Ingelheim|Bisakódýl||||| 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|12714|18014|lyfalmen|V0728|18014|00|84|0|28|D.A.C. ehf|D.A.C. ehf|Rópíníról||12714||12714|18014 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|25125|33466|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|Montelúkast||25125||25125|33466 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3097|4434|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|Própófól||3097||3097|4434 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|3159|5127|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3159||3159|5127 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|5172|7859|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|Búdesóníð||5172||5172|7859 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|5170|7856|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5170||5170|7856 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|16336|22523|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16336||16336|22523 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13244|18674|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||13244||13244|18674 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|9633|13913|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||9633||9633|13913 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|31035|40506|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|Própófól||31035||31035|40506 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|27808|36806|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|Desmópressín||27808||27808|36806 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|40558|52362|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||40558||40558|52362 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27063|35878|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||27063||27063|35878 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4163|6490|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||4163||4163|6490 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|19087|25631|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||19087||19087|25631 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5102|7305|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tranexamsýra||5102||5102|7305 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||21666||21666|29159 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4260|6621|lyfalmen|V1951|6621|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4260||4260|6621 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5451|8238|lyfalmen|V0085|8238|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5451||5451|8238 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|28438|37273|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||28438||28438|37273 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5888|8831|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||5888||5888|8831 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|20290|27446|lyfalmen|||00|98|0|98|Icepharma hf|Eli Lilly Nederland -|||20290||20290|27446 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||21666||21666|29159 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|100975|127581|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||100975||100975|127581 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|791|1561|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||791||791|1561 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45|Actavis Group hf|Actavis Group hf|Natríumflúoríð||||| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|32442|42575|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||32442||32442|42575 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|37927|49404|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||37927||37927|49404 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|40089|52096|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||40089||40089|52096 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|349256|436691|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||349256||349256|436691 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|360316|450461|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||360316||360316|450461 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1424|lyfalmen|V0917|1424|00|20|0|20|Actavis Group hf|Actavis hf|Paroxetín||430||430|1424 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11417|19758|vetorma|||00|24|0|0|Vistor hf|Bayer Animal Health GmbH|||11417||11417|19758 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|26346|34986|lyfalmen|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||26346||26346|34986 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2525|4370|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2525||2525|4370 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3243|5241|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3243||3243|5241 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||2104 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7570|4920|lyfalmen|V0308|3043|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3006||3006|4920 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|11741|7324|lyfalmen|V0310|4428|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||4778||4778|7324 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2391|4138|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2391||2391|4138 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|827|1963|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||827||827|1963 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2403|4101|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2403||2403|4101 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1548|2679|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1548||1548|2679 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5209|7909|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5209||5209|7909 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2400|3240|lyfalmen|V0919|3240|00|100|0|100|Actavis Group hf|Actavis hf|Paroxetín||1768||1768|3240 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|2385|lyfalmen|V0918|2385|00|60|0|60|Actavis Group hf|Actavis hf|Paroxetín||1138||1138|2385 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|1463|2826|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|Metótrexat||1463||1463|2826 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|4369|5620|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|Mesalazín (5-amínósalicýlsýra)||3522||3522|5620 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|15107|20993|lyfalmen|V0192|19299|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15107||15107|20993 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|249353|312312|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||249353||249353|312312 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||2934 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|||67|30|0|10|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|||67|30|0|20|Actavis Group hf|Actavis hf|Ísótretínóín||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27063|35878|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||27063||27063|35878 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21666||21666|29159 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4381|6786|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4381||4381|6786 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6298|9387|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|Darífenacín||6298||6298|9387 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|133866|168531|lyfsjukr|||00|30|0|0|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||133866||133866|168531 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|28641|37843|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||28641||28641|37843 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|44716|57856|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||44716||44716|57856 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|22644|30377|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||22644||22644|30377 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6361|9473|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|Darífenacín||6361||6361|9473 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|22874|30663|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||22874||22874|30663 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|23218|30774|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|Flúmazeníl||23218||23218|30774 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5334|8079|lyfalmen|V0715|8079|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|Gabapentín||5334||5334|8079 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|1|100|XEU|18370|25056|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|Blöndur||18370||18370|25056 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9570|13702|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|Darbepóetín alfa||9570||9570|13702 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|37671|48768|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|Darbepóetín alfa||37671||37671|48768 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28511|37364|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|Darbepóetín alfa||28511||28511|37364 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|67873|86369|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|Darbepóetín alfa||67873||67873|86369 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|45314|58283|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|Darbepóetín alfa||45314||45314|58283 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|9102|13032|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||9102||9102|13032 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|135659|170763|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||135659||135659|170763 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|22756|30199|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||22756||22756|30199 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|18635|25068|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|Darbepóetín alfa||18635||18635|25068 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13917|19512|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13917||13917|19512 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|45513|58531|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||45513||45513|58531 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|91024|115192|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||91024||91024|115192 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9742|14061|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||9742||9742|14061 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|216968|271993|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||216968||216968|271993 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|182049|228519|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||182049||182049|228519 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|19483|26441|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19483||19483|26441 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|14612|20377|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14612||14612|20377 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|155240|195141|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |Tipranavír||155240||155240|195141 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|26029|34591|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||26029||26029|34591 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4742|7276|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4742||4742|7276 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|4014|6288|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|Tímólól||4014||4014|6288 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|71674|91102|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|Saquínavír||71674||71674|91102 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10432|14997|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10432||10432|14997 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|105021|132619|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|Síldenafíl||105021||105021|132619 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|4247|6604|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||4247||4247|6604 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|90934|115080|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|Tigecýklín||90934||90934|115080 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|5443|7793|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|Cefazólín||5443||5443|7793 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4343|6734|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|Fentanýl||4343||4343|6734 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|22004|29580|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||22004||22004|29580 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2272|3253|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2272||2272|3253 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|9756|14080|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||9756||9756|14080 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|17059|23423|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||17059||17059|23423 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|73348|93503|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||73348||73348|93503 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27063|35878|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||27063||27063|35878 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8519|12401|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8519||8519|12401 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|406|1391|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|Terbútalín||406||406|1391 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8519|12401|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8519||8519|12401 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14355|20057|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14355||14355|20057 024510|V04CL0004|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14355|20057|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14355||14355|20057 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14379|20087|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14379||14379|20087 024532|V04CL0007|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14355|20057|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14355||14355|20057 024559|V04CL0008|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14355|20057|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14355||14355|20057 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14526|20270|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14526||14526|20270 024576|V04CL0010|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14355|20057|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14355||14355|20057 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8519|12401|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8519||8519|12401 024589|V04CL0012|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14355|20057|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14355||14355|20057 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|81092|103145|lyfalmen|||00|100|0|125|Vistor hf|Novartis Europharm Ltd|||81092||81092|103145 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14526|20270|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14526||14526|20270 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1749|3214|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1749||1749|3214 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8519|12401|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8519||8519|12401 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8519|12401|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8519||8519|12401 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8519|12401|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8519||8519|12401 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1749|3214|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1749||1749|3214 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|1122|2363|lyfalmen|V0143|2294|70|30|0|30|D.A.C. ehf|D.A.C. ehf|Amíódarón||1122||1122|2363 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|6407|9535|lyfalmen|||00|4|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||6407||6407|9535 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|1021|2226|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1021||1021|2226 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21666||21666|29159 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2922|4806|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2922||2922|4806 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1991|3542|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1991||1991|3542 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3789|5982|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3789||3789|5982 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21666||21666|29159 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|959|2142|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|Cefalexín||959||959|2142 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|15361|21309|lyfalmen|||00|12|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||15361||15361|21309 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|Cefalexín||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|111446|140618|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||111446||111446|140618 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|110177|139038|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||110177||110177|139038 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10736|20622|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||10736||10736|20622 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|19888|26946|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||19888||19888|26946 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|24189|32300|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan||24189||24189|32300 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7056|10416|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|Valsartan||7056||7056|10416 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006|30.06.2009|R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|7232|10655|lyfalmen|||00|28|0|56|D.A.C. ehf|D.A.C. ehf|Escítalópram||7232||7232|10655 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|31956|41970|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|Risperídón||31956||31956|41970 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2095|3683|lyfalmen|V1090|3683|06|5|0|17|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||2095||2095|3683 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|5879|8818|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||5879||5879|8818 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|15333|21275|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||15333||15333|21275 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|3002|4401|lyfalmen|V0989|4401|06|5|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||2624||2624|4401 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|17060|23425|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|Risperídón||17060||17060|23425 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|24675|32905|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|Risperídón||24675||24675|32905 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007|31.05.2009|R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3623|5757|lyfalmen|||23|200|0|100|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3623||3623|5757 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|62092|79490|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||62092||62092|79490 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6792|9724|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||6792||6792|9724 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27063|35878|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||27063||27063|35878 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|925|2096|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||925||925|2096 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3911|6768|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||3911||3911|6768 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|954|2135|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||954||954|2135 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1701|3149|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||1701||1701|3149 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8851|15317|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||8851||8851|15317 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21666||21666|29159 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1909|3431|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Nítrófúrantóín||1909||1909|3431 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|397|1379|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|Nítrófúrantóín||397||397|1379 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|3025|4945|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||3025||3025|4945 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|7637|11204|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Cýpróterón||7637||7637|11204 027281|N06DA0204 |Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|33099|43393|lyfalmen|V0375|43393|00|100|0|67|Actavis Group hf|Actavis hf|Dónepezíl||||33099|43393 027305|N06DA0204 |Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|37146|48432|lyfalmen|V0376|48432|00|100|0|133|Actavis Group hf|Actavis hf|Dónepezíl||||37146|48432 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|73838|93796|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||73838|93796 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|90271|114255|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||90271|114255 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|194841|244445|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||194841|244445 027397|G02CX0102 |Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|5908|8459|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||5908|8459 027408|G02CX0102 |Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|17600|23780|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||17600|23780 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1940|3473|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||1940||1940|3473 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7764|11377|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||7764||7764|11377 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|10393|14944|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||10393||10393|14944 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|13727|19275|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||13727||13727|19275 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|987|2180|lyfalmen|V0431|2009|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||987||987|2180 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|941|2117|lyfalmen|V0430|1828|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||941||941|2117 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|137969|173639|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|Posacónazól||137969||137969|173639 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|26555|35246|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26555||26555|35246 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|26555|35246|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26555||26555|35246 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4405|6818|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4405|6818 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15314|21251|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||15314|21251 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4405|6818|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4405|6818 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15314|21251|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||15314|21251 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|5077|7730|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||5077|7730 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17663|24175|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||17663|24175 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|5077|7730|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||5077|7730 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17663|24175|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||17663|24175 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2832|4684|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2832||2832|4684 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|23777|31787|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||23777||23777|31787 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|9098|13187|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||9098||9098|13187 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1370|2700|lyfalmen|V0712|2700|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Baklófen||1370||1370|2700 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1952|3489|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1952||1952|3489 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3680|5834|lyfalmen|V0351|3898|10|60|0|30|Vistor hf|Ferrosan A/S|Diltíazem||3680||3680|5834 028575|N03AX0901 |Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2575|lyfalmen|||00|56|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2575 028586|N03AX0901 |Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8728|lyfalmen|||00|98|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||5812|8728 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|1011|2212|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat og sýkla­eyðandi lyf||1011||1011|2212 028598|N03AX0901 |Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|14897|lyfalmen|||00|98|0|65|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|14897 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|8910|17143|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||8910||8910|17143 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|988|2181|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||988||988|2181 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13304|18748|lyfalmen|||00|10|0|5|Icepharma hf|Roche as|Granisetrón||13304||13304|18748 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2266|3915|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2266||2266|3915 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1178|2439|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1178|2439 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1046|2260|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||1046||1046|2260 029287|C03DB0105 |Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|275|1214|lyfalmen|||00|28|0|14|Actavis Group hf|Actavis UK Ltd.|||||275|1214 029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|411|1398|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||411||411|1398 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7745|11351|lyfalmen|||0|7|0|0|D.A.C. ehf|D.A.C. ehf|Búdesóníð||||7745|11351 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|9368|6353|lyfalmen|||00|98|0|33|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||4062||4062|6353 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8479|10033|lyfalmen|||00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6774||6774|10033 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|13324|13564|lyfalmen|V0367|3035|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||9376||9376|13564 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|18736|25511|lyfalmen|||00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||18736||18736|25511 029517|L01BB0503 |Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|35140|45617|lyfsjukr|||00|50|0|0|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||35140|45617 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|22615|30023|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||||22615|30023 029574|L01XX1904 |Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|22653|30070|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group hf|Írinótekan||||22653|30070 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|21036|28057|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|Ritonavír||||21036|28057 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|24011|32079|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||24011||24011|32079 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|523|1550|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||523||523|1550 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|2062|3639|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||2062||2062|3639 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyflausa|||00|60|0|25|Icepharma hf|Navamedic ASA|Glúkósamín||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|10355|14893|lyfalmen|V1400|14893|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Klózapín||10355||10355|14893 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3303|5323|lyfalmen|V1401|5323|00|100|0|8|Vistor hf|Novartis Healthcare A/S-|Klózapín||3303||3303|5323 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|915|2082|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Metóprólól||915||915|2082 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1334|2651|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|Metóprólól||1334||1334|2651 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|935|2109|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||935||935|2109 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3536|5639|lyfalmen|||17|10|0|25|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||3536||3536|5639 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5035|7673|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5035||5035|7673 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2141|3746|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Ísósorbíð dínítrat||2141||2141|3746 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|7041|10395|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||7041||7041|10395 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|41458|53483|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|Terlípressín||41458||41458|53483 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1868|3375|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Sótalól||1868||1868|3375 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10810|15326|lyfsjukr|||0|4|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||10810|15326 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|15800|21539|lyfsjukr|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||15800|21539 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|54670|69932|lyfsjukr|||0|50|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||54670|69932 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|27575|36516|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||27575||27575|36516 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4265|7381|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||4265||4265|7381 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|142569|179366|lyfsjukr|||0|6|0|0|Gróco ehf|Serono Nordic|Interferón beta-1a||||142569|179366 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|15166|26246|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||15166||15166|26246 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|490|1505|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|Atrópín||490||490|1505 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1312|2621|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Dexametasón||1312||1312|2621 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|ml|1|hgl||L04AC05|01.06.2009||R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|568735|709943|lyfsjukr|||AC|0|0|0|Vistor hf|Janssen-Cilag International N.V.|||||568735|709943 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2786|5478|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2786|5478 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|839|1979|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||839||839|1979 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2184|3804|lyfalmen|||00|300|0|10|Vistor hf|Astra|Clómetíazól||2184||2184|3804 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|2059|3635|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2059||2059|3635 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3530|5631|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3530||3530|5631 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9955|14253|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|Prótamín||9955||9955|14253 035099|C02CA0404 |Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|10291|14806|lyfalmen|V2120|14806|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Doxazósín||||10291|14806 035155|N03AX1403 |Keppra (D.A.C.)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2009||R|A|3|0|1|E|0|DAC|0|0|0|100|DKK|21222|26927|lyfalmen|V1710|26927|00|100|0|25|D.A.C. ehf|D.A.C. ehf|Levetíracetam||19873||19873|26927 035177|N03AX1203 |Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6724|7942|lyfalmen|V0714|6450|10|100|0|17|D.A.C. ehf|D.A.C. ehf|Gabapentín||5233||5233|7942 035200|N03AX1203 |Neurontin (D.A.C.)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|18765|25547|lyfalmen|V2160|25547|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Gabapentín||||18765|25547 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|19503|26466|lyfalmen|||10|300|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||19503||19503|26466 035222|N06DA0403 |Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|12358|17192|lyfalmen|V1370|17192|00|28|0|14|D.A.C. ehf|D.A.C. ehf|Galantamín||12054||12054|17192 035234|M01AB5502 |Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5755|8216|lyfalmen|V2130|8216|0|100|0|50|D.A.C. ehf|D.A.C. ehf|||5435||5435|8216 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|Lamótrigín||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|V0705|5347|00|56|0|19|Actavis Group hf|Actavis hf|Lamótrigín||3321||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|V0706|8873|00|56|0|37|Actavis Group hf|Actavis hf|Lamótrigín||5919||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|135277|170287|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegaptaníb||135277||135277|170287 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|PCO|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|Digoxín||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|50672|64954|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Fitusambönd||50672||50672|64954 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|1036|2246|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||1036||1036|2246 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|552|1589|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||552||552|1589 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|5890|8833|lyfalmen|||00|60|0|60|Vistor hf|Meda AS|Tenoxíkam||5890||5890|8833 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|245821|307915|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||245821||245821|307915 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|439050|548485|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||439050||439050|548485 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|877675|1094573|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||877675||877675|1094573 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|834|1972|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||834||834|1972 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1332|2648|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1332||1332|2648 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|AstraZeneca A/S DK|Silíkonsambönd||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2630|4409|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2630||2630|4409 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|797|1922|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||797||797|1922 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7393|10873|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7393||7393|10873 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|14785|20592|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||14785||14785|20592 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|28998|38287|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||28998||28998|38287 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|56965|73106|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||56965||56965|73106 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|3175|5149|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3175||3175|5149 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1256|2545|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1256||1256|2545 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|756|1866|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|Trímetóprím||756||756|1866 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2260 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3819 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|2033|3599|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|Trímetóprím||2033||2033|3599 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1489|lyfalmen|V0917|1424|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||478||478|1489 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2556|lyfalmen|V0918|2385|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1264||1264|2556 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3506|lyfalmen|V0919|3240|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1964||1964|3506 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1171|2429|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1171||1171|2429 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|239581|300146|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||239581||239581|300146 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|11191|16027|lyfalmen|||00|90|0|90|Icepharma hf|Servier|Perindópríl||11191||11191|16027 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4929|7529|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |Betahistín||4929||4929|7529 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3332|5362|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||3332||3332|5362 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|41545|53591|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||41545||41545|53591 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|72291|91870|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||72291||72291|91870 039575|D01AE1503 |Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15|D.A.C. ehf|D.A.C. ehf|Terbínafín||||| 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|6449|9592|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||6449||6449|9592 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1652|3082|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1652||1652|3082 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2534|4279|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2534||2534|4279 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|391|560|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||391||391|560 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|0|0|AGP|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3035|00|98|0|131|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1630|3052 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|897|1284|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||897||897|1284 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1591|2278|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1591||1591|2278 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3395|5448|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3395||3395|5448 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Gervitár og aðrar óvirkar sam­setningar|||||1579 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|9581|13842|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Rota-veira, veikluð veira||9581||9581|13842 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|3076|5015|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||3076||3076|5015 041488|N06AB1002 |Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|25574|29655|lyfalmen|V2172|29611|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Escítalópram||22064||22064|29655 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4922|8518|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||4922||4922|8518 041795|M02AA1503 |Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0|D.A.C. ehf|D.A.C. ehf|Díklófenak||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|188914|237383|lyfalmen|||02|100|0|0|Icepharma hf|Schering AG|Gadófosveset||188914||188914|237383 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1415|2761|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól||1415||1415|2761 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|11908|16693|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||11908||11908|16693 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4080|5842|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4080||4080|5842 042309|N01BB0902|Naropin|stl/irl|2|mg/ml|200|ml|5|plpok||N01BB09|01.07.2009||R|A||0|0|0|1|AZD|0|0|0|100|SEK|21298|28384|lyfsjukr|||00|1000|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||||21298|28384 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5146|7368|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5146||5146|7368 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4863|6963|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4863||4863|6963 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7373|10556|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||7373||7373|10556 042346|N07BA0137 |Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|42|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042357|N07BA0141 |Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8464|12118|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||8464||8464|12118 042368|A06AB0602 |Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2456|4173|lyfalmen|||00|500|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2456|4173 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9257|13254|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Kolvetni||9257||9257|13254 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4916|7038|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4916||4916|7038 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3607|5164|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||3607||3607|5164 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3109|4451|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3109||3109|4451 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|10865|15394|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||10865||10865|15394 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4399|6298|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||4399||4399|6298 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2453|3512|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2453||2453|3512 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8109|11610|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Elektrólýtar||8109||8109|11610 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2750|3937|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2750||2750|3937 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|865|2014|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||865||865|2014 042551|B05BB0209 |Glucos 100 mg/ml med Na40 + K20 Fres|irl|0||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3523|5044|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3523|5044 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|16540|22777|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||16540||16540|22777 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3822|5472|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3822||3822|5472 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0|Icepharma hf|Fresenius Kabi|||||| 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|350|1315|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||350||350|1315 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3312|4742|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3312||3312|4742 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|4109|6416|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4109||4109|6416 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6089|8718|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||6089||6089|8718 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|631|1697|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||631||631|1697 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1350|2672|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|Estríól||1350||1350|2672 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|14217|19504|lyfalmen|V0011|19504|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||13911||13911|19504 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|6207|9264|lyfalmen|V1300|9264|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Síldenafíl||6207||6207|9264 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|42402|54658|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Írinótekan||42402||42402|54658 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1453|2812|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||1453||1453|2812 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|8269|12062|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||8269||8269|12062 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2265|lyfalmen|V0362|2265|00|98|0|65|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1050|2265 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||868|2018 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|23674|45267|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||23674||23674|45267 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|5076|7729|lyfalmen|V1088|7729|02|10|0|1|Icepharma hf|Vian SA|Ondansetrón||5076||5076|7729 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|8305|12111|lyfalmen|V1089|12111|02|20|0|2|Icepharma hf|Vian SA|Ondansetrón||8305||8305|12111 047042|L04AB0101|Enbrel|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|86735|109853|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||86735||86735|109853 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|943|2120|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Sótalól||943||943|2120 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1236|2518|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|Amoxicillín||1236||1236|2518 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61073 047560|L04AB0101|Enbrel|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|220573|276481|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||220573||220573|276481 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|9607|13878|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|Zafírlúkast||9607||9607|13878 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4902|7018|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|Albúmín||4902||4902|7018 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7737|11077|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Albúmín||7737||7737|11077 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|2471|4194|lyfalmen|||00|100|0|0|Vistor hf|Meda AB|Klídín og geðlyf||2471||2471|4194 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|15548|21542|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||15548||15548|21542 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4357|6753|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|Ísósorbíð dínítrat||4357||4357|6753 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2009|3567|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||2009||2009|3567 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|72686|92679|lyfalmen|||00|150|0|38|Icepharma hf|Roche|Mýcófenólsýra||72686||72686|92679 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|9093|13180|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|Selegilín||9093||9093|13180 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|540|1573|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||540||540|1573 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|21384|28808|lyfalmen|||00|3|0|0|Icepharma hf|Roche Registration Limited|||21384||21384|28808 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|3061|4994|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Dípýrídamól||3061||3061|4994 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3697|5857|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||3697||3697|5857 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|10880|15605|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||10880||10880|15605 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|8816|12804|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|Amorolfín||8816||8816|12804 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2277|lyfalmen|V0361|2277|00|98|0|33|Portfarma ehf|Portfarma|Simvastatín||1059||1059|2277 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|V0362|2265|00|98|0|65|Portfarma ehf|Portfarma|Simvastatín||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|3097|lyfalmen|V0367|3097|00|100|0|133|Portfarma ehf|Portfarma|Simvastatín||1663||1663|3097 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4259|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|Ramipríl||2519||2519|4259 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2263|3911|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2263||2263|3911 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|Ramipríl||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5619|8033|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|Ciklospórín||5300||5300|8033 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|20619|26697|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|Ciklospórín||19688||19688|26697 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|16831|22442|lyfalmen|V0718|8018|00|12|0|84|D.A.C. ehf|D.A.C. ehf|Alendrónsýra||16271||16271|22442 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|88164|111949|lyfalmen|||00|300|0|38|Icepharma hf|Roche|Mýcófenólsýra||88164||88164|111949 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8931|12787|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||8931||8931|12787 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|610198|739053|lyfsjukr|||00|112|0|0|Vistor hf|Bayer HealthCare AG|Sorafeníb||592117||592117|739053 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4202|6543|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4202||4202|6543 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14986|20843|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14986||14986|20843 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007|30.06.2009|R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3355|5393|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||3355||3355|5393 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|10500|15089|lyfalmen|V2120|14806|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||10500||10500|15089 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|535|1566|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||535||535|1566 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1907|3428|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1907||1907|3428 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0|D.A.C. ehf|D.A.C. ehf|Ketóprófen||||| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|10153|14619|lyfalmen|V0391|14619|00|60|0|0|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||10153||10153|14619 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2532|4276|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2532||2532|4276 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986|31.05.2009|R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|466|1473|lyfalmen|||72|25|0|10|Vistor hf|BioPhausia AB|Acetýlcýstein||466||466|1473 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1104|2339|lyfalmen|V1910|2339|00|30|0|30|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1104||1104|2339 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3328|5357|lyfalmen|V1911|5357|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3328||3328|5357 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1700|3147|lyfalmen|V1912|3147|00|30|0|45|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1700||1700|3147 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4918|7514|lyfalmen|V1913|7514|00|100|0|150|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4918||4918|7514 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986|31.05.2009|R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|1764|3234|lyfalmen|||72|100|0|40|Vistor hf|BioPhausia AB|Acetýlcýstein||1764||1764|3234 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|39220|50696|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|Levetíracetam||39220||39220|50696 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4132|6335|lyfalmen|V0084|6335|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4049||4049|6335 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1909|3043|lyfalmen|V0308|3043|00|100|0|100|Portfarma ehf|Portfarma|Amlódipín||1623||1623|3043 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3111|4428|lyfalmen|V0310|4428|00|100|0|200|Portfarma ehf|Portfarma|Amlódipín||2644||2644|4428 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|431907|539592|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||431907||431907|539592 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|RAN|0|0|0|100|SEK|331|1290|lyfalmen|V0856|1290|00|20|0|10|Actavis Group PTC ehf|Mylan AB|Alprazólam||||331|1290 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|870221|1085293|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||870221||870221|1085293 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|880174|1097684|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||880174||880174|1097684 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2|D.A.C. ehf|D.A.C. ehf|Acíklóvír||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|37116|48077|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|Kalsíumfólínat||37116||37116|48077 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|45777|58860|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|Blöndur||45777||45777|58860 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36778|47656|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|Blöndur||36778||36778|47656 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|49553|63561|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|Kalsíumfólínat||49553||49553|63561 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|42557|54851|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|Blöndur||42557||42557|54851 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35355|45884|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|Blöndur||35355||35355|45884 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|47934|61545|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|Blöndur||47934||47934|61545 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|44596|57390|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|Blöndur||44596||44596|57390 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2758|4583|lyfalmen|V0903|4583|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Zolpidem||2758||2758|4583 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2738|4556|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2738||2738|4556 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|85691|108553|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|Lopinavír||85691||85691|108553 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6620|9824|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6620||6620|9824 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|37608|49007|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||37608||37608|49007 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|11652|16653|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||11652||11652|16653 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|35978|46978|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||35978||35978|46978 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|5590|8426|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||5590||5590|8426 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|124648|157054|lyfsjukr|||43|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||124648||124648|157054 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|588|1638|lyfalmen|V0902|1638|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Zolpidem||588||588|1638 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|16914|23243|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16914||16914|23243 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1297|2600|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1297||1297|2600 054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979|30.04.2009|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1263|2554|lyfalmen|||8|100|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1263||1263|2554 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|896|2056|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||896||896|2056 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2931|4818|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2931||2931|4818 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|1|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|81018|102735|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|Ribavirin||81018||81018|102735 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1368|2697|lyfalmen|||00|200|0|5|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1368||1368|2697 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|14448|27692|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||14448||14448|27692 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8736|15118|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||8736||8736|15118 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|769|1884|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|Erýtrómýcín||769||769|1884 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|13217|18640|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||13217||13217|18640 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|5908|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||3734||3734|5908 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4359|6756|lyfalmen|V0337|6756|00|100|0|50|Actavis Group hf|Actavis hf|Atorvastatín||4359||4359|6756 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|6185|9234|lyfalmen|V0338|9234|00|100|0|100|Actavis Group hf|Actavis hf|Atorvastatín||6185||6185|9234 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|11516|lyfalmen|V0339|11516|00|100|0|200|Actavis Group hf|Actavis hf|Atorvastatín||7867||7867|11516 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1254|2542|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|Erýtrómýcín||1254||1254|2542 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|29649|38781|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||29649||29649|38781 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|273826|342781|lyfsjukr|||00|15|0|30|Icepharma hf|Elan Pharma International|Natalizumab||273826||273826|342781 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|75438|95788|lyfsjukr|||00|30|0|30|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||75438||75438|95788 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|21115|28156|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||21115||21115|28156 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|11220|15836|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||11220||11220|15836 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7305|10459|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||7305||7305|10459 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|6040|8648|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||6040||6040|8648 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|28124|36882|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|Ceftríaxón||28124||28124|36882 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|5456|8244|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5456||5456|8244 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|19411|26352|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||19411||19411|26352 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|22893|30687|lyfalmen|||0|112|0|56|Vistor hf|Pfizer Limited|||||22893|30687 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|484|1497|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||484||484|1497 058283|QI01AD040|Avipro Thymovac|frþlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|183954|318342|vetorma|||00|5000|0|0|Icepharma hf|Lohmann Animal Health|||||183954|318342 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22824|30601|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||22824||22824|30601 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|953|2134|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|Trímetóprím||953||953|2134 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|128538|161897|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||128538||128538|161897 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1587|2994|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1587||1587|2994 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2501|4234|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2501||2501|4234 058924|QI01AD040|Avipro Thymovac|frþlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|A||0|0|0|0|LOH|0|0|0|100|XEU|279444|483592|vetorma|||00|10000|0|0|Icepharma hf|Lohmann Animal Health|||||279444|483592 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4683|7195|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4683||4683|7195 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1590|2998|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|Ísósorbíð dínítrat||1590||1590|2998 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|117648|148657|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||117648||117648|148657 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|35753|46697|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||35753||35753|46697 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|129850|163531|lyfsjukr|||00|30|0|0|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||129850||129850|163531 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|8207|11750|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|Búprenorfín í blöndum||8207||8207|11750 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|515|1539|lyfalmen|V0290|1539|00|98|0|33|Actavis Group PTC ehf|Merck NM AB|Atenólól||515||515|1539 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|18608|25034|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|Búprenorfín í blöndum||18608||18608|25034 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|443840|554766|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||443840||443840|554766 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|224774|282029|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||224774||224774|282029 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|112388|142108|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||112388||112388|142108 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8640|12565|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|Klómípramín||8640||8640|12565 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2010 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||2010 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|3118|6111|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||3118|6111 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1634|3224|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||1634|3224 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|9650|18553|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Animal Health|||||9650|18553 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|8487|11691|lyfalmen|V1030|11691|00|84|0|84|D.A.C. ehf|D.A.C. ehf|Tíbólón||7996||7996|11691 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7996|11691|lyfalmen|V1030|11691|00|84|0|84|Vistor hf|N.V. Organon|Tíbólón||7996||7996|11691 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||2078 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|186625|234216|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Temsirolímus||186625||186625|234216 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8|Actavis Group hf|Actavis hf|Acetýlsalicýlsýra||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7479|10708|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7479||7479|10708 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|19651|26333|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|Daptomýcín||19651||19651|26333 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|27814|36496|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|Daptomýcín||27814||27814|36496 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|574|1619|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||574||574|1619 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5435|8216|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||5435||5435|8216 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|8132|11876|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||8132||8132|11876 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|7958|11394|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|Metótrexat||7958||7958|11394 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|901|1290|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|Metótrexat||901||901|1290 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1208|2480|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1208||1208|2480 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2318|3986|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2318||2318|3986 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|20425|35346|vetorma|||16|1000|0|0|Vistor hf|Bayer Animal Health GmbH|||20425||20425|35346 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|USD|2070|3649|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|Gestóden og östrógen||2070||2070|3649 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|17991|24584|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||17991||17991|24584 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5825|8745|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||5825||5825|8745 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2349|4028|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||2349||2349|4028 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team|Laktúlósa|||||3055 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|2349|3326|lyfalmen|V1901|3326|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Deslóratadín||1832||1832|3326 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|5510|7795|lyfalmen|V1902|7795|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Deslóratadín||5125||5125|7795 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|12457|17376|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||12457||12457|17376 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2874|4974|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2874||2874|4974 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1208|2480|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1208||1208|2480 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2459|4177|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2459||2459|4177 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1230096|1533337|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1230096|1533337 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|492038|614455|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||492038|614455 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2658|4447|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2658||2658|4447 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4920385|6127747|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4920385|6127747 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2460193|3064808|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2460193|3064808 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|990|2184|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||990||990|2184 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2756|4580|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||2756||2756|4580 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|14817|20632|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||14817||14817|20632 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5486||5486|7855 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|6|0|6|Vistor hf|Bayer A/S|Klótrímazól||||| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|1|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|3094|5039|lyfalmen|V1989|4955|06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||3094||3094|5039 065722|S01EE0101 |Xalatan|augndr|50|mcg/ml|2,5|ml|3|glas||S01EE01|01.05.2009||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|8511|12390|lyfalmen|||06|8|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||||8511|12390 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2418|4122|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|Lósartan||2418||2418|4122 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|8171|11929|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||8171||8171|11929 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|37585|48661|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||37585||37585|48661 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|23723|45360|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||23723||23723|45360 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|951|2131|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|Klómípramín||951||951|2131 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|878|2032|lyfalmen|V0908|2032|00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Klómípramín||878||878|2032 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|2519|3313|lyfalmen|V0144|3313|70|30|0|15|D.A.C. ehf|D.A.C. ehf|Amíódarón||1822||1822|3313 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|729|1830|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||729||729|1830 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|8060|11778|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |Betahistín||8060||8060|11778 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1368|2697|lyfalmen|||00|100|0|33|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1368||1368|2697 067632|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7717|14871|vetalmen|||0|10|0|0|Dýraheilsa ehf|Laboratorios SYVA S.A.|||||7717|14871 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|858|2005|lyfalmen|V0901|2005|00|50|0|50|D.A.C. ehf|D.A.C. ehf|Nítrazepam||858||858|2005 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7143|10534|lyfalmen|V0552|10534|10|30|0|8|Actavis Group hf|Actavis hf|Flúkónazól||7143||7143|10534 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|26738|35474|lyfalmen|V0557|35474|10|30|0|30|Actavis Group hf|Actavis hf|Flúkónazól||26738||26738|35474 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6917|13347|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||6917||6917|13347 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2300|3962|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|Flekaíníð||2300||2300|3962 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|6492|9650|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Flekaíníð||6492||6492|9650 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|3033|4956|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|Cefalexín||3033||3033|4956 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1516|2898|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|Cefalexín||1516||1516|2898 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||44276||44276|56991 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|33414|43468|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||33414||33414|43468 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|8027|11493|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||8027||8027|11493 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5709|8174|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||5709||5709|8174 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|10027|14351|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||10027||10027|14351 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6381|9136|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||6381||6381|9136 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5503|10654|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||5503||5503|10654 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|17345|23780|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|Risperídón||17345||17345|23780 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|5827|11271|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||5827||5827|11271 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|Litíum||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|61525|78466|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|Ziconotíð||61525||61525|78466 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|307628|384864|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|Ziconotíð||307628||307628|384864 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8828|16987|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||8828||8828|16987 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|15448|21418|lyfalmen|||00|15|0|5|Icepharma hf|Roche as|Granisetrón||15448||15448|21418 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||21666||21666|29159 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|618|885|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||618||618|885 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|188151|236115|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||188151||188151|236115 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1893|2710|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||1893||1893|2710 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16871|23189|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|Exenatíð||16871||16871|23189 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16871|23189|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|Exenatíð||16871||16871|23189 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1480|2849|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1480||1480|2849 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|4362|5799|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3654||3654|5799 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1854|3356|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1854||1854|3356 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|346|1310|lyfalmen|||00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||346||346|1310 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|932|2105|lyfalmen|||00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||932||932|2105 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1350|2672|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1350||1350|2672 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|585|1634|lyfalmen|V0856|1290|00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||585||585|1634 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1014|2216|lyfalmen|||00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1014||1014|2216 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2014|3573|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2014||2014|3573 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4068|6361|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4068||4068|6361 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|11847|16917|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||11847||11847|16917 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|5191|7885|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5191||5191|7885 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|15278|21206|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15278||15278|21206 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|5191|7885|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5191||5191|7885 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|17149|23535|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||17149||17149|23535 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6217|9277|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|Sibutramin||6217||6217|9277 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|260|1193|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|Díazepam||260||260|1193 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|527|1556|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||527||527|1556 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|23459|40597|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||23459||23459|40597 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2467|4188|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2467||2467|4188 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6217|9277|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|Sibutramin||6217||6217|9277 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1506|2519|lyfalmen|V1910|2339|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1237||1237|2519 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1570|2971|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|Ketókónazól||1570||1570|2971 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2131|3423|lyfalmen|V1912|3147|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1903||1903|3423 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2688|4488|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2688||2688|4488 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2925 075382|V04CL0030|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8411||8411|12255 075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8411||8411|12255 075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8411||8411|12255 075440|V04CL0026|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8411||8411|12255 075465|V04CL0024|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075481|V04CL0023|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075507|V04CL0018|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8411||8411|12255 075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8411||8411|12255 075689|V04CL0027|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8411||8411|12255 075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8411||8411|12255 075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8411||8411|12255 075724|B02BD0901|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|138291|174040|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|Storkuþáttur IX||138291||138291|174040 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2357|4651|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2357||2357|4651 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|25641|34108|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Sítagliptín||25641||25641|34108 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2903|4780|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||2903||2903|4780 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|Portfarma ehf|Portfarma|Risperídón||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|Portfarma ehf|Portfarma|Risperídón||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|Portfarma ehf|Portfarma|Risperídón||2358||2358|4040 076533|N05AB0301 |Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1007|2207|lyfalmen|V2070|2207|00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||||1007|2207 076542|N05AB0301 |Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1397|2736|lyfalmen|V2071|2736|00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||||1397|2736 076551|N05AB0301 |Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1991|3542|lyfalmen|V2072|3542|00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||||1991|3542 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|8074|13972|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||8074||8074|13972 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|6700|9933|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||6700||6700|9933 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|770|1885|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||770||770|1885 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|955|1424|lyfalmen|V0609|1424|10|30|0|15|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1424 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|491|1507|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||491||491|1507 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|748|1855|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||748||748|1855 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|1226|2504|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Flúoxetín||1226||1226|2504 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Flúoxetín||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|3077|5016|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Míanserín||3077||3077|5016 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|5803|8308|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||5803||5803|8308 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17094|23150|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||17094||17094|23150 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18983|25501|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||18983||18983|25501 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|147399|185379|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|Interferón beta-1b||147399||147399|185379 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10051|6558|lyfalmen|V0197|5469|00|98|0|98|Icepharma hf|M.S.D.|Lósartan||4213||4213|6558 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2222|3181|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||2222||2222|3181 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3836|5492|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||3836||3836|5492 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|6893|9869|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||6893||6893|9869 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3786|5978|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3786||3786|5978 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|7755|11103|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||7755||7755|11103 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|22604|30327|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|Perfenazín||22604||22604|30327 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|12138|16979|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||12138||12138|16979 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2340|3350|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2340||2340|3350 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2538|4285|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2538||2538|4285 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|6716|9954|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||6716||6716|9954 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3621|5754|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3621||3621|5754 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|34368|59476|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||34368||34368|59476 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|27145|35663|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||27145||27145|35663 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|53926|69005|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||53926||53926|69005 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|39673|51578|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|Natríumhýalúrónat||39673||39673|51578 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|6552|9732|lyfalmen|V1350|9732|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||6552|9732 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|1325|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||357||357|1325 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998|30.04.2009|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|6606|9805|lyfalmen|||00|28|0|37|Vistor hf|Bristol-Myers Squibb|Pravastatín||6606||6606|9805 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2334|3342|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|Mídazólam||2334||2334|3342 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|21648|29137|lyfalmen|V0813|29137|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Olanzapín||21648||21648|29137 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5632|8483|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5632||5632|8483 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9531|13774|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9531||9531|13774 082040|D07XC0101|Diprosalic|áburður|0||100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3751|5931|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||||3751|5931 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0|Ísaga ehf|AGA AB|Súrefni||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3443|5513|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3443||3443|5513 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|649|1721|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||649||649|1721 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5625|8474|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5625||5625|8474 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1014|2216|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1014||1014|2216 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1621|3040|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1621||1621|3040 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5094|7753|lyfalmen|||00|100|0|6|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5094||5094|7753 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5597|8436|lyfalmen|||00|40|0|12|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5597||5597|8436 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14795|20605|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14795||14795|20605 082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.04.2009|R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|27497|36419|lyfalmen|||00|112|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||27497||27497|36419 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|17742|24274|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|Anastrózól||17742||17742|24274 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|15451|21421|lyfalmen|V1372|21421|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||15451||15451|21421 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7117|10498|lyfalmen|||00|40|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7117||7117|10498 083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.04.2009|R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|26353|34994|lyfalmen|||00|112|0|37|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||26353||26353|34994 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|48786|62924|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|Follitrópín alfa||48786||48786|62924 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|99119|125588|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|Follitrópín alfa||99119||99119|125588 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|86347|109370|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|Ritonavír||86347||86347|109370 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|33529|43929|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||33529||33529|43929 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8632|12359|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8632||8632|12359 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|302|1250|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||302||302|1250 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|583|1632|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||583||583|1632 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|71402|90763|lyfsjukr|||00|0|0|38|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||71402||71402|90763 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|Kínín||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|93107|117786|lyfsjukr|||00|0|0|50|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||93107||93107|117786 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|111008|140072|lyfsjukr|||00|0|0|62|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||111008||111008|140072 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|23947|31682|lyfsjukr|||00|0|0|12|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||23947||23947|31682 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Kínín||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|35835|46482|lyfsjukr|||00|0|0|19|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||35835||35835|46482 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|47668|61214|lyfsjukr|||00|0|0|25|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||47668||47668|61214 084751|B03XA0301 |Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|14211|19560|lyfsjukr|||00|0|0|8|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||14211|19560 084778|B03XA0301 |Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|54171|69310|lyfsjukr|||00|0|0|30|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||54171|69310 084787|B03XA0301 |Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|166841|209585|lyfsjukr|||00|0|0|90|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||166841|209585 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1043|2256|lyfalmen|||00|10|0|1|Vistor hf|Eisai Ltd|Rúfínamíð||1043||1043|2256 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|12057|17196|lyfalmen|||00|60|0|3|Vistor hf|Eisai Ltd|Rúfínamíð||12057||12057|17196 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|40195|52228|lyfalmen|||00|100|0|29|Vistor hf|Eisai Ltd|Rúfínamíð||40195||40195|52228 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|21920|29475|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||21920||21920|29475 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|6411|7407|lyfalmen|||0|98|0|49|Actavis Group hf|Actavis Group hf|Ómeprazól||4839||4839|7407 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4287|lyfalmen|V2170|4287|0|56|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4287 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4530|6988|lyfalmen|V2171|6988|0|98|0|98|Actavis Group hf|Actavis Group hf|Ómeprazól||||4530|6988 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5306|lyfalmen|||0|28|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5306 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3414|5473|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Levófloxacín||3414||3414|5473 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|33529|43929|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||33529||33529|43929 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|847|1990|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||847||847|1990 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|14717|20190|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||14717||14717|20190 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|22817|30592|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|Menótrópín||22817||22817|30592 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|40594|52725|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|Menótrópín||40594||40594|52725 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5232|5899|lyfalmen|V1911|5357|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3728||3728|5899 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6292|8320|lyfalmen|V1913|7514|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5512||5512|8320 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|9382|13433|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9382||9382|13433 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|15493|21156|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15493||15493|21156 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|71358|90708|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||71358||71358|90708 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|83271|105540|lyfsjukr|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||83271||83271|105540 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3634|5772|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|Tíbólón||3634||3634|5772 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|Silíkonsambönd||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|180653|226780|lyfsjukr|||00|60|0|15|Vistor hf|Pfizer Limited|Maravíroc||180653||180653|226780 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|281|1222|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||281||281|1222 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|247|1176|lyfalmen|V0886|1166|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||247||247|1176 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2926|4811|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2926||2926|4811 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||01|500|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EME|0|0|0|100|SEK|811|1941|lyfalmen|||00|5|0|28|MedFarm ehf|E. Merck AB|Klómífen||811||811|1941 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|16611|22866|lyfalmen|V0560|22866|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||16611||16611|22866 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|27301|35857|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||27301||27301|35857 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|44468|57230|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||44468||44468|57230 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|91021|115189|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||91021||91021|115189 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1475|2842|lyfalmen|||00|120|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1475||1475|2842 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1705|3154|lyfalmen|||14|20|0|20|Vistor hf|Meda AB|Nabúmeton||1705||1705|3154 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|8450|12307|lyfalmen|||14|100|0|100|Vistor hf|Meda AB|Nabúmeton||8450||8450|12307 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|514|1538|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||514||514|1538 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16806|18633|lyfalmen|V1111|15244|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan||13211||13211|18633 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|182177|228678|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||182177|228678 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|55282|58840|lyfalmen|V0561|58840|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||45506||45506|58840 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1353|2676|lyfalmen|V0408|2195|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Estradíól||1353||1353|2676 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|180653|226780|lyfsjukr|||00|60|0|30|Vistor hf|Pfizer Limited|Maravíroc||180653||180653|226780 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2332|4005|lyfalmen|V0352|1798|00|100|0|25|Vistor hf|Ferrosan A/S|Diltíazem||2332||2332|4005 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|45664|58719|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||45664||45664|58719 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|228315|286120|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||228315||228315|286120 090460|L04AB0102|Enbrel (Lyfjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|88904|112553|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|Etanercept||88904||88904|112553 090469|L04AB0102|Enbrel (Lyfjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|185382|232668|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|Etanercept||185382||185382|232668 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1713|3165|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1713||1713|3165 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|942|2119|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||942||942|2119 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|V0351|3898|10|60|0|30|Actavis Group hf|Actavis hf|Diltíazem||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|146055|183706|lyfsjukr|||00|28|0|0|Lyfjaver ehf|Lyfjaver ehf|Glatíramer acetat||146055||146055|183706 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1905|2371|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |Glímepíríð||1128||1128|2371 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3428|3269|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |Glímepíríð||1790||1790|3269 092005|N06AB1001 |Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|4327|6712|lyfalmen|||00|15|0|30|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4327|6712 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|146076|183732|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||146076||146076|183732 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|188104|236057|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||188104||188104|236057 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|8172|15738|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||8172||8172|15738 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7628|11192|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7628||7628|11192 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|11510|14893|lyfalmen|V1400|14893|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Klózapín||10355||10355|14893 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|29601|39038|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||29601|39038 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|29601|39038|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||29601|39038 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5844|8771|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5844||5844|8771 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|29557|51150|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||29557||29557|51150 093625|B03AA0702|Ferlen-R|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|100|0|50|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|16847|22842|lyfsjukr|||00|5|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||16847||16847|22842 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|19798|26833|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |Oxýcódon||19798||19798|26833 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|65273|83450|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |Oxýcódon||65273||65273|83450 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2197|3822|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2197||2197|3822 093824|N06AB0403|Cipramil (D.A.C.)|filmhtfl|20|mg|28|stk|1|þpakki||N06AB04|01.03.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3553|3848|lyfalmen|V0923|2562|0|28|0|28|D.A.C. ehf|D.A.C. ehf|Cítalópram||2216||2216|3848 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4393|6802|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||4393||4393|6802 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2929|4815|lyfalmen|V0385|4815|23|84|0|84|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2929||2929|4815 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1991|3929|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||1991||1991|3929 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|14529|20274|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14529||14529|20274 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|20811|28095|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||20811||20811|28095 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|93643|118771|lyfalmen|||00|50|0|50|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||93643||93643|118771 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|46855|60519|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|Metýlnaltrexónbrómíð||46855||46855|60519 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3695|5855|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|Dísúlfíram||3695||3695|5855 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16484|22708|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16484||16484|22708 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|39697|51608|lyfalmen|||00|56|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||39697||39697|51608 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16484|22708|lyfalmen|||00|28|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16484||16484|22708 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|35972|46970|lyfalmen|||00|56|0|56|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||35972||35972|46970 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|16484|22708|lyfalmen|||00|28|0|42|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16484||16484|22708 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|63336|81038|lyfalmen|||00|56|0|84|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||63336||63336|81038 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4065|7914|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4065||4065|7914 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5364|10389|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5364||5364|10389 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9769|18780|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9769||9769|18780 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2558|3662|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|Mesna||2558||2558|3662 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|15274|20884|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||15274||15274|20884 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|152740|192029|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||152740||152740|192029 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1565|2964|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1565||1565|2964 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17962|24548|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17962||17962|24548 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|882|1904|lyfalmen|V1500|1904|07|5|0|0|D.A.C. ehf|D.A.C. ehf|Fúsidínsýra||784||784|1904 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1082687|1349813|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1082687|1349813 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|994081|1239498|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||994081|1239498 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1046077|1304233|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1046077|1304233 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|3|0|1|0|1|CEE|0|0|0|100|XEU|1148678|1431972|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1148678|1431972 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17962|24548|lyfalmen|||00|30|0|30|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17962||17962|24548 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1718|3172|lyfalmen|||00|30|0|18|Icepharma hf|Servier|Indapamíð||1718||1718|3172 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|35925|46912|lyfalmen|||00|60|0|60|Vistor hf|Novartis Europharm Ltd|Rívastigmín||35925||35925|46912 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|99058|125195|lyfsjukr|||00|1|0|1|Vistor hf|Pfizer Limited|Anidulafungin||99058||99058|125195 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|3834|4080|lyfalmen|V0426|4080|00|20|0|5|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2387||2387|4080 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1241|2524|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1241||1241|2524 097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|68955|79033|lyfalmen|V0563|79033|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Letrózól||61725||61725|79033 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||13690||13690|18912 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1945|3480|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1945||1945|3480 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9741|7942|lyfalmen|V0714|6450|10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5233||5233|7942 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12760|10554|lyfalmen|V0715|8079|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||7158||7158|10554 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4450|4050|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |Glímepíríð||2365||2365|4050 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1656|3088|lyfalmen|V1151|3088|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1656||1656|3088 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|7333|10792|lyfalmen|V1110|10792|00|98|0|98|Actavis Group hf|Actavis hf|Valsartan||7333||7333|10792 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|10614|15244|lyfalmen|V1111|15244|00|98|0|196|Actavis Group hf|Actavis hf|Valsartan||10614||10614|15244 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|18917|25737|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||18917||18917|25737 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|3539|5643|lyfalmen|||00|30|0|30|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||3539|5643 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|11777|16822|lyfalmen|||00|100|0|100|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||11777|16822 098486|G03GA002|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|12806|18128|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||12806|18128 098504|G03GA002|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|118789|150077|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||118789|150077 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2450|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||1186||1186|2450 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22586|30305|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||22586||22586|30305 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|799|1925|lyfalmen|V1500|1904|07|5|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||799||799|1925 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|5697|8571|lyfalmen|V0725|8571|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||5697||5697|8571 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|13009|18381|lyfalmen|V0726|18381|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||13009||13009|18381 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|21051|28393|lyfalmen|V0727|28393|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||21051||21051|28393 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|637|1705|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|Tramadól||637||637|1705 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|47716|61274|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||47716||47716|61274 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|70633|89806|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||70633||70633|89806 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|51666|66192|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||51666||51666|66192 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|114716|144689|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||114716||114716|144689 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14648|20422|lyfalmen|||00|28|0|7|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14648|20422 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14648|20422|lyfalmen|||00|28|0|14|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14648|20422 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|13797|19362|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|Lutropin alfa||13797||13797|19362 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997|31.05.2009|R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|2089|3675|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||2089||2089|3675 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|19149|26025|lyfalmen|V2160|25547|0|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||19149||19149|26025 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|32279|42372|lyfalmen|||0|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||32279||32279|42372 101386|R06AX1301|Clarityn|saft|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|41389|53714|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|Lutropin alfa||41389||41389|53714 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|137964|173950|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|Lutropin alfa||137964||137964|173950 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2060|3636|lyfalmen|||00|28|0|19|Vistor hf|Bayer HealthCare AG|Nífedipín||2060||2060|3636 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|6462|9610|lyfalmen|||00|98|0|65|Vistor hf|Bayer HealthCare AG|Nífedipín||6462||6462|9610 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2689|4489|lyfalmen|V1152|4489|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2689||2689|4489 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|9569|13826|lyfalmen|V1153|13826|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||9569||9569|13826 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9824|14172|lyfalmen|V0736|11450|00|100|0|50|D.A.C. ehf|D.A.C. ehf|Tramadól||9824||9824|14172 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|12285|23572|vetalmen|||0|250|0|0|Vistor hf|Boehringer Ingelheim|||||12285|23572 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1500|2876|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1500||1500|2876 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3435|5502|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3435||3435|5502 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2396|3430|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||2396||2396|3430 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|4972|7119|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||4972||4972|7119 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|7906|10307|lyfalmen|V0198|10307|00|98|0|98|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||6976||6976|10307 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|2,25|0|0|B|0|POF|0|0|0|100|XEU|13089|16514|lyfalmen|V0193|16514|00|98|0|196|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||11550||11550|16514 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|4295|5469|lyfalmen|V0197|5469|00|98|0|98|Portfarma ehf|Portfarma|Lósartan||3411||3411|5469 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2732|4012|lyfalmen|V0507|4012|00|10|0|2|Portfarma ehf|Portfarma|Valacíklóvír||2337||2337|4012 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|11357|14008|lyfalmen|V0508|13968|00|40|0|7|Portfarma ehf|Portfarma|Valacíklóvír||9703||9703|14008 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|15375|16923|lyfalmen|V0955|16923|00|100|0|75|Portfarma ehf|Portfarma|Venlafaxín||11851||11851|16923 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|29261|26785|lyfalmen|V0956|26785|00|100|0|150|Portfarma ehf|Portfarma|Venlafaxín||19759||19759|26785 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma|Bisakódýl|||||1869 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1|Vistor hf|Orion Pharma|Bisakódýl||||| 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.05.2009||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|12995|10155|lyfalmen|V0933|6361|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Sertralín||6864||6864|10155 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|4143|6463|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4143||4143|6463 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2860|4722|lyfalmen|||00|21|0|21|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2860||2860|4722 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|9237|13375|lyfalmen|||04|28|0|19|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9237||9237|13375 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|6066|9072|lyfalmen|||56|700|0|5|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6066||6066|9072 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5871|8808|lyfalmen|||10|100|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5871||5871|8808 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5432||5432|7777 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4132|6335|lyfalmen|V0084|6335|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4049||4049|6335 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|14394|19528|lyfalmen|V0087|19527|00|100|0|67|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13930||13930|19528 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|19431|26377|lyfalmen|V0089|26377|00|100|0|133|D.A.C. ehf|D.A.C. ehf|Esómeprazól||19431||19431|26377 105315|G03AA0705 |Microgynon (D.A.C.)|töflur|0||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1106|2341|lyfalmen|||23|63|0|84|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||||1106|2341 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|21372|28793|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|Tíagabín||21372||21372|28793 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|17632|24137|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|Tíagabín||17632||17632|24137 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|32060|42100|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|Tíagabín||32060||32060|42100 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|8816|12804|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|Tíagabín||8816||8816|12804 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|16029|22141|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|Tíagabín||16029||16029|22141 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|11754|16791|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|Tíagabín||11754||11754|16791 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4405|6818|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4405||4405|6818 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15314|21251|lyfalmen|||00|98|0|98|Vistor hf|Novartis Europharm Ltd|||15314||15314|21251 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|5077|7730|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|||5077||5077|7730 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17663|24175|lyfalmen|||00|98|0|196|Vistor hf|Novartis Europharm Ltd|||17663||17663|24175 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2424|4130|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2424||2424|4130 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2640|4423|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2640||2640|4423 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3721|5890|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3721||3721|5890 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|0|100|0|50|Portfarma ehf|Portfarma|Enalapríl||802||802|1929 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|0|100|0|100|Portfarma ehf|Portfarma|Enalapríl||1153||1153|2405 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|0|100|0|200|Portfarma ehf|Portfarma|Enalapríl||2725||2725|4538 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|20079|26866|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||20079||20079|26866 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|11104|15692|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||11104||11104|15692 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|18433|25134|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||18433||18433|25134 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|16103|22233|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||16103||16103|22233 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|24243|32368|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||24243||24243|32368 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1996|3549|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||1996||1996|3549 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|18433|25134|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||18433||18433|25134 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis hf|Paracetamól||||| 107583|N03AF0202 |Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6004|8215|lyfalmen|V2150|8215|00|100|0|30|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||5434||5434|8215 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||2975 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1117|2356|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|Ranitidín||1117||1117|2356 108209|N02BE0106|Parasupp|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.05.2009|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|3163|5133|lyfalmen|||63|100|0|33|Vistor hf|Bayer HealthCare AG|Nífedipín||3163||3163|5133 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|4877|7459|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Vildagliptín||4877||4877|7459 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|13303|18747|lyfalmen|||00|90|0|45|Vistor hf|Novartis Europharm Ltd|Vildagliptín||13303||13303|18747 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1238|2443|vetalmen|||27|1200|0|0|Icepharma hf|Kela Laboratoria NV|||1238||1238|2443 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1080|2306|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1080||1080|2306 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1642|3069|lyfalmen|||24|120|0|38|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1642||1642|3069 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|Tramadól||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|Tramadól||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|237|1162|lyfalmen|V0775|1151|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||237||237|1162 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|905|2069|lyfalmen|V0780|2048|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||905||905|2069 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|27063|35878|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||27063||27063|35878 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|21666|29159|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||21666||21666|29159 109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8411|12255|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8411||8411|12255 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Paracetamól||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|712|1807|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||712||712|1807 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|795|1919|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||795||795|1919 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0|Ísaga ehf|AGA AB|Súrefni||||| 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1716|3169|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||1716||1716|3169 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|5028|7664|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|Verapamíl||5028||5028|7664 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|12907|18254|lyfalmen|V1351|18254|00|8|0|16|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||12907|18254 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|836|1975|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||836||836|1975 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|899|2060|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|Gentamícín||899||899|2060 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1428|2778|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||1428||1428|2778 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3939|6186|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3939||3939|6186 112641|M05BA0407 |Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|9157|13267|lyfalmen|V0718|8018|00|12|0|84|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||||9157|13267 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10754|15434|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10754|15434 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|29601|39038|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||29601|39038 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10754|15434|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10754|15434 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3634|5772|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3634||3634|5772 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|29601|39038|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||29601|39038 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5894|8839|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5894||5894|8839 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|38861|50249|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||38861||38861|50249 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|820857|1023834|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|Nilotiníb||820857||820857|1023834 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|660|1736|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||660||660|1736 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|964|2149|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||964||964|2149 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1280|2577|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1280||1280|2577 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|851|1995|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||851||851|1995 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|3240|lyfalmen|V0919|3240|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1768||1768|3240 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|2385|lyfalmen|V0918|2385|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1138||1138|2385 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1424|lyfalmen|V0917|1424|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||430||430|1424 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2624|4401|lyfalmen|V0989|4401|06|5|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||2624||2624|4401 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4626|7118|lyfalmen|||0|750|0|3|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||4626||4626|7118 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1863|3369|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1863||1863|3369 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|13868|19451|lyfalmen|||0|2250|0|10|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||13868||13868|19451 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|27735|36715|lyfalmen|||0|4500|0|20|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||27735||27735|36715 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4626|7118|lyfalmen|||0|1100|0|5|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||4626||4626|7118 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|13868|19451|lyfalmen|||0|3300|0|15|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||13868||13868|19451 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|27735|36715|lyfalmen|||0|6600|0|30|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||27735||27735|36715 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2139|3743|lyfalmen|V1090|3683|06|5|0|17|Icepharma hf|M.S.D.|Dorzólamíð||2139||2139|3743 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1353|2676|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|Cýpróheptadín||1353||1353|2676 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3930|6174|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3930||3930|6174 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0|Icepharma hf|Norpharma |Malatíón||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|4216|6036|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||4216||4216|6036 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2204|3156|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2204||2204|3156 116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994|30.04.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994|30.04.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1802|3286|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1802||1802|3286 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10|Icepharma hf|Galderma Nordic AB|||||| 116327|D07AC1301 |Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3338|5370|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3338|5370 116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1792|3272|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1792||1792|3272 116418|D07AC1301 |Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3338|5370|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3338|5370 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Íbúprófen||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Actavis Group hf|Actavis hf|Íbúprófen||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|882|2037|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||882||882|2037 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|494|1511|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Íbúprófen||494||494|1511 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1193|2459|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Íbúprófen||1193||1193|2459 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|20308|27468|lyfalmen|||00|84|0|84|Vistor hf|Pfizer Limited|||||20308|27468 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7187|10593|lyfalmen|||00|28|0|28|Vistor hf|Pfizer Limited|||||7187|10593 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7634|11200|lyfalmen|||00|28|0|56|Vistor hf|Pfizer Limited|||||7634|11200 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|23002|30822|lyfalmen|||00|84|0|168|Vistor hf|Pfizer Limited|||||23002|30822 116985|N06AX1607 |Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|USD|17879|23919|lyfalmen|V0955|16585|00|98|0|74|D.A.C. ehf|D.A.C. ehf|Venlafaxín||17457||17457|23919 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|41166|53437|lyfalmen|V1702|53437|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||41166||41166|53437 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|41166|53437|lyfalmen|V1703|53437|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||41166||41166|53437 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|10107|19424|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||10107||10107|19424 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|8630|12552|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||8630||8630|12552 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6506|9669|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||6506||6506|9669 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|13608|19127|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||13608|19127 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|24050|32127|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||24050|32127 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2683|4481|lyfalmen|||10|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2683||2683|4481 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4159|6484|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4159|6484 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|41586|53960|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||41586|53960 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|48101|62071|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||48101|62071 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10837|18754|vetorma|||00|250|0|0|Vistor hf|Bayer Animal Health GmbH|||10837||10837|18754 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2898|4773|lyfalmen|||61|28|0|28|Vistor hf|Bayer HealthCare AG|Nífedipín||2898||2898|4773 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|5098|7759|lyfalmen|||61|98|0|98|Vistor hf|Bayer HealthCare AG|Nífedipín||5098||5098|7759 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|8289|12089|lyfalmen|||61|98|0|196|Vistor hf|Bayer HealthCare AG|Nífedipín||8289||8289|12089 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|7060|13619|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||7060||7060|13619 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|12382|23757|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||12382||12382|23757 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4454|4514|lyfalmen|V0809|4514|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2707||2707|4514 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|6330|5651|lyfalmen|V0810|5651|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3545||3545|5651 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|24549|21197|lyfalmen|V0812|21197|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||15271||15271|21197 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18754|16672|lyfalmen|V0815|16672|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11666||11666|16672 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1898|3416|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1898||1898|3416 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15|Actavis Group hf|Actavis hf|Ranitidín||||| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|793|1917|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||793||793|1917 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7950|11629|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||7950||7950|11629 118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|19300|17130|lyfalmen|V0811|17130|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12004||12004|17130 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|10248|14747|lyfalmen|||00|50|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||10248||10248|14747 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|30143|39713|lyfalmen|||00|150|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||30143||30143|39713 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3965|5323|lyfalmen|V1401|5323|00|100|0|8|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3303||3303|5323 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|11680|14893|lyfalmen|V1400|14893|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Klózapín||10355||10355|14893 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|93691|118513|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|Panitúmúmab||93691||93691|118513 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|14155|19808|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl og þvagræsilyf||14155||14155|19808 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Portfarma ehf|Portfarma|Íbúprófen||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|522276|652419|lyfalmen|||00|30|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|||||522276|652419 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|522276|652419|lyfalmen|||00|30|0|40|GlaxoSmithKline ehf|Glaxo Group Limited|||||522276|652419 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1015|2218|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|Cýklópentólat||1015||1015|2218 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|52430|67143|lyfsjukr|||00|1|0|0|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||52430|67143 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13481|17192|lyfalmen|V1370|17192|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|Galantamín||12054||12054|17192 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|41484|50492|lyfalmen|V1371|50492|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|Galantamín||38801||38801|50492 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|DKK|3581|5571|lyfalmen|V0939|5524|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3486||3486|5571 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|22649|30383|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||22649||22649|30383 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|21655|29145|lyfalmen|V1710|26927|00|100|0|25|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||||21655|29145 121164|A02BC0501 |Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5564|8391|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||5564|8391 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|793|1917|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Tríazólam||793||793|1917 121286|M03AC0901 |Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11001|15564|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||||11001|15564 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|387|1366|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||387||387|1366 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|438|1435|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||438||438|1435 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2234|3872|lyfalmen|V0908|2032|00|100|0|25|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2234||2234|3872 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3439|5507|lyfalmen|||98|30|0|10|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3439||3439|5507 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|615|1675|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Díazepam||615||615|1675 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|959|2142|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Díazepam||959||959|2142 123253|L02BB0301|Casodex|töflur|150|mg|28|stk|1|þpakki||L02BB03|01.06.2009||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|55632|65909|lyfalmen|V0561|54917|00|28|0|84|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||51184||51184|65909 123264|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|13492|18983|lyfalmen|||0|28|0|2|Actavis Group hf|Alpharma ApS|Vankómýcín||||13492|18983 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|USD|2501|4234|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||2501||2501|4234 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|27020|35825|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|Vankómýcín||||27020|35825 123308|R03BB0404 |Spiriva (Lyfjaver)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.05.2009||R|A|2|0|0|B|0|LVR|0|0|0|100|DKK|7572|11116|lyfalmen|V2110|10237|00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|Tíótrópíumbrómíð||||7572|11116 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|14292|19979|lyfalmen|V1080|19376|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||14292||14292|19979 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|349|1314|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||349||349|1314 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|43825|56747|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|Rílúzól||43825||43825|56747 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|974|2162|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||974||974|2162 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1115|2353|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1115||1115|2353 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Enalapríl||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl||1153||1153|2405 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|2569|3313|lyfalmen|V0144|3313|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||1822||1822|3313 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|24105|27425|lyfalmen|V1701|27425|00|28|0|6|D.A.C. ehf|D.A.C. ehf|Aripiprazól||20273||20273|27425 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|20056|20850|lyfalmen|V1732|20850|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14992||14992|20850 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|17795|20653|lyfalmen|V1730|20653|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14834||14834|20653 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|22577|22363|lyfalmen|V1731|22363|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||16207||16207|22363 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|121795|153502|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||121795|153502 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|31257|40782|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||31257|40782 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|28264|37056|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||28264||28264|37056 126561|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.09.2008|30.06.2009|R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|14|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126572|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.09.2008|30.06.2009|R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126583|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|28|stk|1|þpakki||A02BC03|01.09.2008|30.06.2009|R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|9421|13489|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||9421||9421|13489 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1813|3301|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|Lóperamíð||1813||1813|3301 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|XEU|4517|6623|lyfalmen|V1951|6621|00|28|0|14|D.A.C. ehf|D.A.C. ehf|||4261||4261|6623 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9715|6640|lyfalmen|V0810|5651|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||4274||4274|6640 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstil|0||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6761|13050|vetalmen|||0|30|0|0|Vistor hf|Boehringer Ingelheim Danmark|||||6761|13050 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|509|1531|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Verapamíl||509||509|1531 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1374|2705|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1374||1374|2705 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4406|6308|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Mesna||4406||4406|6308 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|32812|18402|lyfalmen|V0811|17130|00|56|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||13026||13026|18402 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|38068|22816|lyfalmen|V0812|21197|00|56|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||16571||16571|22816 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||2875 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5204|7902|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||5204||5204|7902 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|17024|20679|lyfalmen|V0726|18381|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|Quetíapín||14855||14855|20679 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26947|31464|lyfalmen|V0727|28393|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||23517||23517|31464 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2143|3749|lyfalmen|||63|10|0|20|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||||2143|3749 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4456|6887|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4456||4456|6887 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|2231|3868|lyfalmen|||63|10|0|3|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||||2231|3868 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12680|17972|lyfalmen|||0|53|0|21|Vistor hf|Pfizer Limited|||||12680|17972 130772|QI10A0001 |Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|61874|118032|vetalmen|||0|500|0|0|Vistor hf|PHARMAQ AS|||||61874|118032 131136|R03CA0202|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||R03CA02|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|3067|5002|lyfalmen|||00|10|0|10|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||3067|5002 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|432|1427|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Fenýtóín||432||432|1427 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|829|1965|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||829||829|1965 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|908|2073|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||908||908|2073 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|1005|2204|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||1005||1005|2204 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6060|9064|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|Estradíól||6060||6060|9064 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|8248|12033|lyfalmen|||0|10|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||8248|12033 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|24744|32991|lyfalmen|||0|30|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||24744|32991 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|82478|104870|lyfalmen|||0|100|0|0|Vistor hf|Bayer HealthCare AG|Rivaroxaban||||82478|104870 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|273|1125|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||210||210|1125 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|359|1242|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||296||296|1242 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|13746|19299|lyfalmen|V0192|19299|00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||13746||13746|19299 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9513|13750|lyfalmen|V0191|13750|00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||9513||9513|13750 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1596|3006|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Kódein||1596||1596|3006 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8185|11948|lyfalmen|||0|30|0|27|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||8185|11948 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||23|8|0|8|Icepharma hf|Napp|Joð/pólývídón||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1157|2410|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Proxýmetakaín||1157||1157|2410 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3|Vistor hf|Abigo Medical AB|Lyfjakol||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|907|2071|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||907||907|2071 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|89025|112704|lyfsjukr|||02|5|0|4|Vistor hf|Chugai sanofi-aventis|Lenógrastím||89025||89025|112704 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|36228|46971|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||36228|46971 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|40476|52260|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||40476|52260 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|44973|57859|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||44973|57859 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|9713|14021|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|Rífampicín||9713||9713|14021 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|123131|155166|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|Voricónazól||123131||123131|155166 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2642|4426|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2642||2642|4426 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|2837|4062|lyfsjukr|||0|5|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||2837|4062 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4239|6069|lyfsjukr|||0|10|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||4239|6069 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|11863|16637|lyfsjukr|||0|25|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||11863|16637 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|184045|230900|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||183962||183962|230900 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997|31.05.2009|R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|4364|6763|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||4364||4364|6763 135111|H01AC0101|Genotropin|sts|0| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|80270|101804|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||80270||80270|101804 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|1008|2208|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Verapamíl||1008||1008|2208 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2410|4111|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2410||2410|4111 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|907|2071|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||907||907|2071 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6741|9988|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|Ísóníazíð||6741||6741|9988 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|110711|139703|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||110711||110711|139703 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|81980|103933|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||81980||81980|103933 136964|L01CD0102|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17799|24027|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||17799|24027 136975|L01CD0102|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|88013|111444|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||88013|111444 136987|L01CD0102|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|35851|46502|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||35851|46502 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|102863|129932|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||102863|129932 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1653|3084|lyfalmen|V2071|2736|00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||1653||1653|3084 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1096|2328|lyfalmen|V2070|2207|00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||1096||1096|2328 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1610 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||2028 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|174402|218998|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|Ranibizumab||174402||174402|218998 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4850|7422|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4850||4850|7422 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|31177|40683|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||31177||31177|40683 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|12857|17874|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||12857||12857|17874 137831|M05BA0303|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|16855|22852|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||16855||16855|22852 137842|M05BA0304|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|22146|29439|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||22146||22146|29439 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2388|3419|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||2388||2388|3419 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|3246|4647|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||3246||3246|4647 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2236|3875|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|Tímólól||2236||2236|3875 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2375|4063|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|Tímólól||2375||2375|4063 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|3022|5230|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||3022||3022|5230 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3323|5350|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3323||3323|5350 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|3039|4964|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|Metformín||3039||3039|4964 140130|V03AB3501 |Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|189587|237903|lyfsjukr|||00|20|0|0|Vistor hf|N.V. Organon|||||189587|237903 140141|V03AB3501 |Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|473969|591959|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|||||473969|591959 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2795|4633|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2795||2795|4633 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1891|3407|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |Pramipexól||1891||1891|3407 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|15671|21378|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||15671||15671|21378 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|706|1011|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||706||706|1011 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1495|2869|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1495||1495|2869 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|3343|5377|lyfalmen|V2002|5377|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Blöndur||||3343|5377 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1507|2885|lyfalmen|||08|80|0|0|D.A.C. ehf|D.A.C. ehf|Amoxicillín||||1507|2885 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|9863|14121|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|Paracetamól||9863||9863|14121 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|15546|21540|lyfalmen|V0011|19504|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||15546||15546|21540 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|29894|39086|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|Voricónazól||29894||29894|39086 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3655|5800|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |Pramipexól||3655||3655|5800 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4462|5529|lyfalmen|||0|84|0|0|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3455||3455|5529 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2008||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|725|1824|lyfalmen|||00|28|0|7|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||||725|1824 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9547|13796|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|Pramipexól||9547||9547|13796 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|483|1496|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|Própranólól||483||483|1496 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|620|1682|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Própranólól||620||620|1682 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|8561|12257|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||8561||8561|12257 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1071|2294|lyfalmen|V0143|2294|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1071||1071|2294 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2636|4418|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Metenamín||2636||2636|4418 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|858|2005|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Própranólól||858||858|2005 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2278|3932|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||2278||2278|3932 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5113|7321|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||5113||5113|7321 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|810|1940|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|Prednisólón||810||810|1940 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1370|2700|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||1370||1370|2700 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3722|5891|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||3722||3722|5891 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|955|2136|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Trópíkamíð||955||955|2136 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1936|3468|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1936||1936|3468 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2474|4198|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Klónidín||2474||2474|4198 143631|A10BD0701|Janumet|filmhtfl|0||56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|9624|13901|lyfalmen|||0|56|0|0|Icepharma hf|M.S.D.|||||9624|13901 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|11983|6665|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Cítalópram||4292||4292|6665 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|1021|2226|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1021||1021|2226 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1334|2651|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Litíum||1334||1334|2651 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3095|5040|lyfalmen|V0429|5001|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||3095||3095|5040 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4683|6705|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||4683||4683|6705 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|9000|12886|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||9000||9000|12886 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|4185|6520|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||4185||4185|6520 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5273|7996|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5273||5273|7996 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|15832|21578|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||15832||15832|21578 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|106474|134428|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|Sómatrópín||106474||106474|134428 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28|Actavis Group hf|Actavis Group hf|Ómeprazól||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|66853|85099|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|Sómatrópín||66853||66853|85099 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|43467|55984|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|Sómatrópín||43467||43467|55984 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|998|2195|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||998||998|2195 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|464|1470|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||464||464|1470 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|801|1927|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||801||801|1927 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3530|5631|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3530||3530|5631 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5476|8272|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5476||5476|8272 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0|Vistor hf|Recip AB|Pýrvín||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0|Vistor hf|Recip AB|Pýrvín||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0|Vistor hf|Recip AB|Pýrvín||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|23222|31096|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||23222||23222|31096 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|11532|16225|lyfsjukr|||0|2|0|0|Icepharma hf|Hospira UK Ltd|Írinótekan||||11532|16225 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|HUK|0|0|0|100|XEU|27318|35878|lyfsjukr|||0|5|0|0|Icepharma hf|Hospira UK Ltd|Írinótekan||||27318|35878 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|838|1978|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||838||838|1978 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|5355|7667|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||5355|7667 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4518|6469|lyfsjukr|||0|10|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4518|6469 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981|30.06.2009|R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1360|2686|lyfalmen|||00|50|0|50|Vistor hf|LEO Pharma A/S|Medroxýprógesterón||1360||1360|2686 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|13427|18584|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||13427||13427|18584 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|21464|28590|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||21464||21464|28590 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|45042|57945|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|Gentamícín||45042||45042|57945 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|125386|158291|lyfalmen|||00|750|0|30|Icepharma hf|Roche as|Dornase alfa||125386||125386|158291 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1177|2438|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1177||1177|2438 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HON|0|0|0|100|SEK|23406|31008|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Nordic AB (V)|Raltítrexed||23406||23406|31008 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|17382|20937|lyfalmen|V2001|20937|00|120|0|120|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||15062||15062|20937 148950|N06DA0203 |Aricept (D.A.C.)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|51953|66866|lyfalmen|V0375|42525|00|98|0|65|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||51953|66866 148961|N06DA0203 |Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|56213|72170|lyfalmen|V0376|47463|00|98|0|131|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||56213|72170 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16848|20993|lyfalmen|V0192|19299|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan og þvagræsilyf||15107||15107|20993 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|4038|7863|vetalmen|||27|25|0|0|Vistor hf|Bayer Animal Health GmbH|||4038||4038|7863 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1719|3173|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1719||1719|3173 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|15030|20897|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|Rífampicín||15030||15030|20897 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3909|6145|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3909|6145 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7971|11657|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7971||7971|11657 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1130|2374|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1130||1130|2374 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|17727|24255|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||17727|24255 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|54734|70329|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||54734|70329 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|6678|7638|lyfalmen|V0437|7230|00|90|0|90|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||5009||5009|7638 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1787|3265|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1787||1787|3265 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1232|2512|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1232||1232|2512 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|777|1112|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Baklófen||777||777|1112 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4166|6494|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4166||4166|6494 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6448|9591|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6448||6448|9591 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10796|15491|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||10796||10796|15491 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1753|3219|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|Ítracónazól||1753||1753|3219 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Cetirizín||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1878|3389|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1878||1878|3389 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Cetirizín||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2124|3723|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2124||2124|3723 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1697|3143|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||1697||1697|3143 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|3845|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Cetirizín||2214||2214|3845 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|412069|514893|lyfsjukr|||00|10|0|14|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||412069||412069|514893 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|5874|8812|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|Ítracónazól||5874||5874|8812 153575|M01AH0102 |Celebra (D.A.C.)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|15420|20918|lyfalmen|V2140|20918|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Celekoxíb||15047||15047|20918 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|7610|11168|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|Hýdroxókóbalamín||7610||7610|11168 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154464|D05AX5203 |Xamiol|hlaup|0||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|5234|7943|lyfalmen|||00|30|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||5234|7943 154475|D05AX5203 |Xamiol|hlaup|0||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|10024|14443|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||10024|14443 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6131|9160|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||6131||6131|9160 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1500|2876|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1500||1500|2876 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5435|8216|lyfalmen|V2130|8216|10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5435||5435|8216 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12988|18355|lyfalmen|V0438|15809|00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||12988||12988|18355 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1376|2708|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1376||1376|2708 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1872|3381|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1872||1872|3381 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|580|1627|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||580||580|1627 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|11113|15921|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|Ítracónazól||11113||11113|15921 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|7042|10397|lyfalmen|||00|42|0|14|Icepharma hf|Roche|Orlístat||7042||7042|10397 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9381|13571|lyfalmen|||00|84|0|28|Icepharma hf|Roche|Orlístat||9381||9381|13571 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|3|0|0|0|0|JAS|0|0|0|100|SEK|358|1326|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||358||358|1326 156964|N07BA0137 |Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156986|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156997|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157020|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157031|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|8120|14052|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||8120||8120|14052 157419|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|204|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157430|N07BA0140 |Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157463|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|96|0|6|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|554|1592|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||554||554|1592 157909|D07XC0101|Diprosalic|áburður|0| |100|ml|1|glas||D07XC01|01.01.1987|30.06.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3615|5746|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3615||3615|5746 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1121|2362|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1121||1121|2362 158431|B02BD0801 |NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|115194|145284|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||115194|145284 158442|B02BD0801 |NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|230390|288703|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||230390|288703 158453|B02BD0801 |NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|653264|815181|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||653264|815181 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|58866|75156|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||58866|75156 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|92713|117295|lyfsjukr|||0|1|0|1|Vistor hf|Astellas Pharma GmbH|||||92713|117295 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1247|2533|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||1247||1247|2533 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|945|2123|lyfalmen|V0608|2123|10|100|0|50|Actavis Group PTC ehf|Mylan AB|Díklófenak||||945|2123 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2230|3867|lyfalmen|V2003|3867|00|98|0|31|D.A.C. ehf|D.A.C. ehf|Metóprólól||||2230|3867 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3911|6148|lyfalmen|V1050|6148|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||3911|6148 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7531|11060|lyfalmen|V1051|11060|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||7531|11060 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10538|15141|lyfalmen|V1052|15141|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||10538|15141 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|12668|17957|lyfalmen|V1053|17957|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||12668|17957 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7235|4916|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3003||3003|4916 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|28648|37852|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||28648||28648|37852 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|14811|13411|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9263||9263|13411 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2094|2679|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1355||1355|2679 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|3626|3848|lyfalmen|V0923|2562|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2216||2216|3848 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7471|5188|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3204||3204|5188 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|189264|237501|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||189264||189264|237501 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2532|3625|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||2532||2532|3625 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|956|2138|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||956||956|2138 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2637|4419|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2637||2637|4419 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|357|1325|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|Díklófenak||||357|1325 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|373|1347|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||373||373|1347 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|83433|105742|lyfsjukr|||0|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||||83433|105742 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|854|1999|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||854||854|1999 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1997|2859|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||1997||1997|2859 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3425|4904|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||3425||3425|4904 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|783|1903|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||783||783|1903 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5394|8160|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|Estradíól||5394||5394|8160 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|67245|85905|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||67245||67245|85905 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|3601|5156|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||3601||3601|5156 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|7073|10127|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||7073||7073|10127 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|22339|29680|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||22339||22339|29680 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2639|4422|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2639||2639|4422 162929|G04CA0205 |Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|5300|8033|lyfalmen|V0437|8033|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||||5300|8033 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2410|4111|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2410||2410|4111 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1328|2643|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||||1328|2643 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1844|3343|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1844||1844|3343 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|226|1147|lyfalmen|||0|20|0|20|Actavis hf|Actavis EAD|||||226|1147 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3212|5199|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3212||3212|5199 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|11887|lyfalmen|||00|454|1|0|Distica|Distica - óskráð lyf|||8140||8140|11887 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|3032|4955|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||3032||3032|4955 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2758|4583|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Selegilín||||2758|4583 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|6737|9983|lyfalmen|V0299|9983|98|60|0|20|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6737||6737|9983 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5346|8095|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|Felódipín||5346||5346|8095 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4667|7174|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|Felódipín||4667||4667|7174 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3012|4928|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|Felódipín||3012||3012|4928 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16098|22227|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||16098||16098|22227 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|950|2130|lyfalmen|||00|100|0|50|Vistor hf|UCB Nordic A/S|Meklózín||950||950|2130 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|337|1298|lyfalmen|||00|25|0|12|Vistor hf|UCB Nordic A/S|Meklózín||337||337|1298 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5|Vistor hf|UCB Nordic A/S|Meklózín||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||227395||227395|284974 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2764|4591|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|Dexklórfeníramín||2764||2764|4591 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|985|2177|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||985||985|2177 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2536|4282|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2536||2536|4282 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16970|23313|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||16970||16970|23313 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 166709|G04CA0103|Alfuzosin Ranbaxy|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.07.2009||R|A||0|0|E|0|RAN|0|0|0|100|XEU|11030|15809|lyfalmen|V0438|15809|00|90|0|120|Gróco ehf|Ranbaxy (UK) Ltd|Alfúzósín||||11030|15809 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|27833|36520|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||27833||27833|36520 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|55665|71170|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||55665||55665|71170 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|671|1751|lyfalmen|||00|100|0|25|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||671|1751 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1279|2576|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1279||1279|2576 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3409|5467|lyfalmen|V0789|5467|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3409||3409|5467 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1339|2657|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1339||1339|2657 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7779|11397|lyfalmen|V0713|11085|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||7779||7779|11397 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|50142|64294|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||50142||50142|64294 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|227739|285403|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||227739||227739|285403 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2876|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1500||1500|2876 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|27094|35600|lyfsjukr|||00|5|0|5|Icepharma hf|Roche as|Gancíklóvír||27094||27094|35600 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|6003|8987|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||6003||6003|8987 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2425 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1718 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1706 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1374 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3345|5380|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3345||3345|5380 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3593|5716|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3593||3593|5716 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|27131|35646|lyfsjukr|||00|4|0|0|Icepharma hf|Roche Registration Limited|||||27131|35646 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|67335|85700|lyfsjukr|||00|10|0|0|Icepharma hf|Roche Registration Limited|||||67335|85700 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5497|8300|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||5497||5497|8300 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|A||0|1|0|1|RRL|0|0|0|100|DKK|133978|168670|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|||||133978|168670 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5455|8243|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|Própafenón||5455||5455|8243 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|10018|14435|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|Própafenón||10018||10018|14435 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2301|3963|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||2301||2301|3963 170697|M05BA0406 |Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|5289|8018|lyfalmen|V0718|8018|00|12|0|84|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||||5289|8018 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|||10|30|0|2|Icepharma hf|NordMedica A/S|Vankómýcín||10000||10000|14411 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3370|5414|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3370||3370|5414 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3631|5768|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3631||3631|5768 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|732|1834|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||732||732|1834 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4114|6423|lyfalmen|V0709|6422|00|60|0|5|Vistor hf|Janssen-Cilag AB|Tópíramat||4114||4114|6423 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6772|10030|lyfalmen|V0710|10030|00|60|0|10|Vistor hf|Janssen-Cilag AB|Tópíramat||6772||6772|10030 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|50322|64518|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||50322||50322|64518 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|43228|55686|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||43228||43228|55686 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|12229|17410|lyfalmen|V0711|17410|00|60|0|20|Vistor hf|Janssen-Cilag AB|Tópíramat||12229||12229|17410 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|25080|33410|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|Tópíramat||25080||25080|33410 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|75131|95406|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||75131||75131|95406 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|3062|4996|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||3062||3062|4996 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|13694|19234|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||13694||13694|19234 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7421|10911|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |Hýdrómorphón||7421||7421|10911 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|14163|19818|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |Hýdrómorphón||14163||14163|19818 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|23555|31511|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |Hýdrómorphón||23555||23555|31511 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2561|4316|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2561||2561|4316 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2561|4316|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2561||2561|4316 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3647|5790|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3647||3647|5790 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989|30.06.2009|R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|903|2066|lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ketókónazól||903||903|2066 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|27042|35852|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |Hýdrómorphón||27042||27042|35852 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|875|2028|lyfalmen|V0901|2005|00|50|0|50|Vistor hf|Meda AB|Nítrazepam||875||875|2028 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2653|4441|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2653||2653|4441 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3716 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|5664|8527|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||5664||5664|8527 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|1017|2220|lyfalmen|||00|10|0|10|Vistor hf|Meda AS|Tenoxíkam||1017||1017|2220 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|325|1281|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|Zópíklón||325||325|1281 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Distica|Distica - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Distica|Distica - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1537|2201|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|Díazepam||1537||1537|2201 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|621|1683|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||621||621|1683 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|635|1702|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||635||635|1702 174433|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1898|3416|lyfalmen|||00|5|0|25|Vistor hf|Allergan|||||1898|3416 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|240|1166|lyfalmen|V0886|1166|00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Zópíklón||||240|1166 174664|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5568|8396|lyfalmen|||00|15|0|150|Vistor hf|Allergan|||||5568|8396 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2731|4012|lyfalmen|V0507|4012|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||2337||2337|4012 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7752|4922|lyfalmen|V0809|4514|00|28|0|7|Icepharma hf|Eli Lilly Nederland -|Olanzapín||3008||3008|4922 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4495|6940|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4495||4495|6940 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|785|1906|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||785||785|1906 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|707|1395|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||707||707|1395 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|818|1950|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|Betametasón||818||818|1950 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|632|1698|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|Tríamcínólón||632||632|1698 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11767|16517|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||11767||11767|16517 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6429|9565|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|Olsalazín||6429||6429|9565 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|17137|23521|lyfalmen|||00|98|0|65|Vistor hf|Bristol-Myers Squibb|Pravastatín||17137||17137|23521 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|972|2159|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón og sýkingalyf||972||972|2159 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|824|1959|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||824||824|1959 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||23|50|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8324|16027|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||8324||8324|16027 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|11520|16210|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Metótrexat||11520||11520|16210 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|43485|56006|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|Metótrexat||43485||43485|56006 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|IBV|0|0|0|100|DKK|5452|10556|vetalmen|||16|100|0|0|Vistor hf|Intervet International BV|||5452||5452|10556 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|6026|11650|vetalmen|||27|50|0|0|Vistor hf|Intervet International BV|||6026||6026|11650 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1328|2643|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1328||1328|2643 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|920|2089|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||920||920|2089 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1702|3150|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||1702||1702|3150 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|4674|7183|lyfalmen|||98|700|0|5|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4674||4674|7183 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|26057|34626|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Letrózól||26057||26057|34626 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|61725|79033|lyfalmen|V0563|79033|00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Letrózól||61725||61725|79033 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5126|7797|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5126||5126|7797 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A|3|0|0|B|0|MNA|0|1|0|100|SEK|1101|2334|lyfalmen|V1140|2334|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|Míanserín||1101||1101|2334 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|5152|7832|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||5152||5152|7832 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3273|5282|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3273||3273|5282 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2273|3925|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2273||2273|3925 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000|30.06.2009|R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|51875|66769|lyfalmen|||00|30|0|90|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||51875||51875|66769 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|11635|16353|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|Deferoxamín||11635||11635|16353 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3395|5448|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||3395||3395|5448 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1148|2398|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1148||1148|2398 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|555|1594|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||555||555|1594 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|902|2064|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Indómetacín||902||902|2064 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|488|1503|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Indómetacín||488||488|1503 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1982|3530|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Indómetacín||1982||1982|3530 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4997|7154|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4997||4997|7154 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|5096|7296|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||5096||5096|7296 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6580|9421|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||6580||6580|9421 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|5|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|555|1594|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klóramfeníkól||555||555|1594 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1796|3278|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1796||1796|3278 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|500|1519|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||500||500|1519 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|753|1862|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|Dexklórfeníramín||753||753|1862 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2085 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1258|2548|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1258||1258|2548 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|1254|1795|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|Metótrexat||1254||1254|1795 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2298|3959|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2298||2298|3959 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|553|1591|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||553||553|1591 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||639||639|1708 194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|39687|51278|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||39687||39687|51278 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1960|3500|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||1960||1960|3500 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4252|6611|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||4252||4252|6611 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4164|6491|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||4164||4164|6491 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1310|2618|lyfalmen|||00|250|0|83|Actavis Group PTC ehf|Mylan AB|Atenólól||||1310|2618 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|8076|11800|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||8076||8076|11800 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2152|3761|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2152||2152|3761 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|879|2033|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||879||879|2033 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|958|2140|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|Lóperamíð||958||958|2140 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|24248|32374|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|Etónógestrel||24248||24248|32374 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|740|1845|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||740||740|1845 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|356|1323|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|Fenýlprópanólamín||356||356|1323 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|844|1986|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|Fenýlprópanólamín||844||844|1986 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|A||0|0|B|0|MYL|0|0|0|100|SEK|1635|3059|lyfalmen|||00|250|0|167|Actavis Group PTC ehf|Mylan AB|Atenólól||||1635|3059 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1344|2664|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1344||1344|2664 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2857|5613|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2857||2857|5613 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|13603|26083|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||13603||13603|26083 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6486 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|851|1995|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||851||851|1995 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|V0705|5347|00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|951|2131|lyfalmen|V0857|2131|00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||951||951|2131 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4507|6957|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||4507||4507|6957 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2627|4405|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2627||2627|4405 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1516|lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||498||498|1516 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1850|3351|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||1850||1850|3351 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|11346|15993|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúóróúracíl||11346||11346|15993 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|464|664|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||464||464|664 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|41414|53745|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estramústín||41414||41414|53745 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||17114||17114|23174 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|984|2176|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||984||984|2176 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8563|12461|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||8563||8563|12461 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|62893|80169|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|Abciximab||62893||62893|80169 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4982|7601|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||4982||4982|7601 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4615|7103|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||4615||4615|7103 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|Skópólamín||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|637|912|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|Fýtómenadíón||637||637|912 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|19445|26077|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||19445||19445|26077 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|544|779|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|Cefazólín||544||544|779 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9021 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5|Actavis Group hf|Actavis hf|Ranitidín||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|3079|5019|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3079||3079|5019 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|8633|12556|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||8633||8633|12556 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4596|7077|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4596||4596|7077 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996|30.04.2009|R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|17118|23497|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Alendrónsýra||17118||17118|23497 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|10294|14810|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||10294||10294|14810 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|133635|168243|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||133635||133635|168243 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|266839|334082|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||266839||266839|334082 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|613838|766096|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||613838||613838|766096 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2786|4621|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|Desógestrel og östrógen||2786||2786|4621 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|27295|36167|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||27295||27295|36167 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4688|7202|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4688||4688|7202 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|7323|10778|lyfalmen|V0992|10775|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||7323|10778 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|9584|13846|lyfalmen|V0993|13845|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||9584|13846 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3251|5252|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||3251||3251|5252 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|702|1793|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|Metformín||702||702|1793 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5513|8322|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|Tamsúlósín||5513||5513|8322 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|12314|17516|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12314||12314|17516 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|20720|27981|lyfalmen|V0560|22866|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||20720||20720|27981 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2778|4610|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||2778||2778|4610 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7981|11671|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7981||7981|11671 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|8875|12884|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8875||8875|12884 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|12099|17248|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12099||12099|17248 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4991|7613|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4991||4991|7613 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|40830|53018|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||40830||40830|53018 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|11926|14666|lyfalmen|V0508|14666|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||10188||10188|14666 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|175246|220049|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||175246||175246|220049 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|182533|229121|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||182533||182533|229121 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|228864|286803|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||228864||228864|286803 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1677|3116|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|Díazepam||1677||1677|3116 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|2073|3654|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|Díazepam||2073||2073|3654 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|29078|38070|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||29078||29078|38070 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|116757|147230|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||116757||116757|147230 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6667|9888|lyfalmen|||17|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6667||6667|9888 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6219|9280|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6219||6219|9280 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|16873|3438|lyfalmen|V0367|3035|00|98|0|131|Icepharma hf|M.S.D.|Simvastatín||1914||1914|3438 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6437|9576|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Bambúteról||6437||6437|9576 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1904 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8610|14900|vetorma|||00|20|0|0|Vistor hf|Bayer Animal Health GmbH|||8610||8610|14900 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Actavis Group hf|Actavis hf|Ketókónazól||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120|Actavis Group hf|Actavis hf|Ketókónazól||||| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|58010|74407|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|Anastrózól||58010||58010|74407 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|813|1604|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||813||813|1604 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|249494|312488|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||249494||249494|312488 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3412|5471|lyfalmen|V2002|5377|00|25|0|5|Vistor hf|AstraZeneca A/S DK|Blöndur||3412||3412|5471 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3848|6062|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|Blöndur||3848||3848|6062 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|7181|10585|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||7181||7181|10585 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2645|4430|lyfalmen|V0388|4430|23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2645||2645|4430 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2417|4120|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2417||2417|4120 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|998|2195|lyfalmen|V0408|2195|00|84|0|84|Vistor hf|BioPhausia AB|Estradíól||998||998|2195 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|709|1803|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|Estradíól||709||709|1803 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|340645|425971|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||340645||340645|425971 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1081|2307|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1081||1081|2307 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|13304|18748|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Granisetrón||13304||13304|18748 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985|30.06.2009|R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2534|4279|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Flúkloxacillín||2534||2534|4279 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3258|5262|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|Nýstatín||3258||3258|5262 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7808|11436|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||7808||7808|11436 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3348|5384|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||3348||3348|5384 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|15047|20918|lyfalmen|V2140|20918|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||15047||15047|20918 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3108|5058|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||3108||3108|5058 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5591|10821|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||5591||5591|10821 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|1030|2238|lyfalmen|||00|30|0|30|Icepharma hf|Galderma Nordic AB|Adapalen||1030||1030|2238 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|197373|247597|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||197373||197373|247597 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|11977|16779|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|Capecitabín||11977||11977|16779 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|63615|81068|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|Capecitabín||63615||63615|81068 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|V0706|8873|00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|10067|14502|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10067||10067|14502 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1713|3165|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1713||1713|3165 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6213|9272|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||6213||6213|9272 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|404|1389|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||404||404|1389 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|658|1733|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||658||658|1733 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|287|1230|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||287||287|1230 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8|Vistor hf|McNeil Denmark ApS|Nikótín||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|846|1988|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||846||846|1988 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1354|2678|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1354||1354|2678 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|728|1828|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||728||728|1828 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1775|3503|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1775||1775|3503 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|IBV|1|0|0|100|DKK|5733|11092|vetalmen|||27|20|0|0|Vistor hf|Intervet International BV|||5733||5733|11092 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7810|11439|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|Ísradipín||7810||7810|11439 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1369|2698|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1369||1369|2698 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1812 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|110475|139409|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|Alteplasi||110475||110475|139409 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|699|1001|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|Fýtómenadíón||699||699|1001 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1917|3442|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1917||1917|3442 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|23655|31635|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||23655||23655|31635 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23005|30826|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23005||23005|30826 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23005|30826|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23005||23005|30826 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23005|30826|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23005||23005|30826 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|23235|31113|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23235||23235|31113 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|70048|89395|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||70048||70048|89395 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|75975|96774|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||75975||75975|96774 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|81902|104153|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||81902||81902|104153 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7764|11377|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||7764||7764|11377 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|639|1708|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|Indómetacín||639||639|1708 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2099|3689|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2099||2099|3689 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|272|1209|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||272||272|1209 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|766|1880|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||766||766|1880 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1184|2447|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1184||1184|2447 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5434|8215|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5434||5434|8215 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1184|2447|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1184||1184|2447 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3236|5232|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3236||3236|5232 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5817|8734|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5817||5817|8734 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|4297|6672|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4297||4297|6672 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|4088|6388|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4088||4088|6388 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|13880|19466|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13880||13880|19466 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3386|5435|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3386||3386|5435 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|11812|22671|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||11812||11812|22671 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1621|lyfalmen|V0290|1570|00|100|0|33|Actavis Group hf|Actavis hf|Atenólól||||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|11247|16103|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||11247||11247|16103 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1220|2496|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Klórókín||1220||1220|2496 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|714|1809|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|Tretínóín||714||714|1809 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|625|1689|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|Baklófen||625||625|1689 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|8160|11683|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|Mídazólam||8160||8160|11683 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|27162|35684|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín||27162||27162|35684 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2076|3658|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2076||2076|3658 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8497|12371|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||8497||8497|12371 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|23993|32056|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|Góserelín||23993||23993|32056 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3547|5078|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3547||3547|5078 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|11167|21443|vetalmen|||02|100|0|0|Vistor hf|Merial|||11167||11167|21443 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|2071|3651|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||2071||2071|3651 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1323|2636|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||1323||1323|2636 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|116363|146739|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||116363||116363|146739 413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|30132|39382|lyfsjukr|||00|4|0|1|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||30132||30132|39382 413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|30132|39382|lyfsjukr|||00|2|0|1|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||30132||30132|39382 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|2026|3590|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2026||2026|3590 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|5066|7715|lyfalmen|||00|90|0|54|Icepharma hf|Servier|Indapamíð||5066||5066|7715 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1619|3037|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1619||1619|3037 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2283|3939|lyfalmen|||5|15|0|15|Vistor hf|Novo-Nordisk|Estradíól||2283||2283|3939 415687|V08BA0101|E-Z-HD|mixtduft|0| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988|30.04.2009|R|A|4|0|0|0|1|EZE|0|0|0|100|USD|15945|21719|lyfsjukr|||08|288|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||15945||15945|21719 415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988|30.04.2009|R|A|2|0|0|0|1|EZE|0|0|0|100|USD|44829|57680|lyfsjukr|||00|384|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||44829||44829|57680 415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988|30.04.2009|R|A|2|0|0|0|1|EZE|0|0|0|100|USD|56038|71635|lyfsjukr|||00|480|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||56038||56038|71635 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|3992|6258|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||3992||3992|6258 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10574|10307|lyfalmen|V0198|10307|00|98|0|98|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||6976||6976|10307 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3849|6064|lyfalmen|||00|300|1|15|Distica|Distica - óskráð lyf|Ranitidín||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3224|5216|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||3224||3224|5216 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|27109|35936|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||27109||27109|35936 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1132|2377|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1132||1132|2377 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|590|1164|vetalmen|||00|10|0|0|Vistor hf|Merial|||590||590|1164 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|44457|57216|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Abacavír||44457||44457|57216 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4654|7156|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4654||4654|7156 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1942|3476|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Betametasón||1942||1942|3476 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|9466|13686|lyfalmen|V0299|9983|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||9466||9466|13686 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2173|4288|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2173||2173|4288 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2821|5545|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2821||2821|5545 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4555|7022|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Alfakalsídól||4555||4555|7022 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10757|15438|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Alfakalsídól||10757||10757|15438 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|74520|94645|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|Doxórúbicín||74520||74520|94645 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|61784|78789|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|Indínavír||61784||61784|78789 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|52236|66901|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||52236||52236|66901 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|898|2059|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||898||898|2059 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|13452|18933|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13452||13452|18933 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|13476|18645|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13476||13476|18645 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|4017|6292|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||4017||4017|6292 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|6856|10144|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||6856||6856|10144 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1822|3313|lyfalmen|V0144|3313|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1822||1822|3313 422121|C07AB0205 |Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1562|2960|lyfalmen|||00|28|0|33|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1562|2960 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3431|5496|lyfalmen|||43|98|0|62|Vistor hf|AstraZeneca A/S DK|Metóprólól||3431||3431|5496 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6758|10011|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|Metóprólól||6758||6758|10011 422402|G03FB0505|Estracomb|forðapl|0| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2861|4723|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Noretísterón og östrógen||2861||2861|4723 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|8782|12758|lyfalmen|||49|100|0|50|Vistor hf|Meda AS|Brómókriptín||8782||8782|12758 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||2260 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|981|2172|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||981||981|2172 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|30475|40126|lyfalmen|||52|100|0|25|Vistor hf|Meda AS|Brómókriptín||30475||30475|40126 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3816|6019|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3816||3816|6019 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|621|1683|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||621||621|1683 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|811|1941|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||811||811|1941 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2541 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1109|2345|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1109||1109|2345 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1101|2334|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1101||1101|2334 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|32027|41741|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||32027||32027|41741 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|50157|64313|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||50157||50157|64313 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|559|1599|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||559||559|1599 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|923|2093|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|Amoxicillín||923||923|2093 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Atenólól||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|6195|9247|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||6195||6195|9247 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|46342|59881|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||46342||46342|59881 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6396|9520|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||6396||6396|9520 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1815|2599|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||1815||1815|2599 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2176|3115|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|Mídazólam||2176||2176|3115 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|4269|8303|vetalmen|||27|100|0|0|Vistor hf|Intervet International BV|||4269||4269|8303 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2832|4684|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2832||2832|4684 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|849|1993|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||849||849|1993 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1256|2545|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|Ísósorbíð dínítrat||1256||1256|2545 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|Diltíazem||785||785|1906 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||952||952|2132 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|12336|17543|lyfalmen|V0729|17543|0|100|0|20|Vistor hf|Orion Corporation|Entakapón||12336||12336|17543 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2767|4595|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2767||2767|4595 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5075|7727|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5075||5075|7727 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6787|10051|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6787||6787|10051 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8497|12371|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||8497||8497|12371 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9789|14125|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||9789||9789|14125 433722|J01EE0104|Primazol sterkar|töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1500|lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||486||486|1500 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1438 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1524|2909|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|Blöndur||1524||1524|2909 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|6470|9620|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6470||6470|9620 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|6470|9620|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6470||6470|9620 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|12017|17146|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||12017||12017|17146 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|6178|9224|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6178||6178|9224 435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998|30.04.2009|R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|2064|3641|lyfalmen|||00|3|0|3|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2064||2064|3641 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5160|7843|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5160||5160|7843 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|7624|9867|lyfalmen|V0725|8571|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6652||6652|9867 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2923|4807|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|Ísósorbíð dínítrat||2923||2923|4807 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4152|6475|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4152||4152|6475 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10948|15697|lyfalmen|V0191|13750|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||10948||10948|15697 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6509|9673|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6509||6509|9673 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|1095|2326|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||1095||1095|2326 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|7164|10562|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7164||7164|10562 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12989|18356|lyfalmen|V0728|18014|00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12989||12989|18356 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|27609|36558|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||27609||27609|36558 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|827|1963|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||827||827|1963 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|2044|3614|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||2044||2044|3614 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|819|1952|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|Naproxen||819||819|1952 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3383|5431|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|Naproxen||3383||3383|5431 436808|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3869|6091|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||3869||3869|6091 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|953|2134|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|Halóperídól||953||953|2134 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3338|5370|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|Halóperídól||3338||3338|5370 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|13479|18966|lyfalmen|V0955|16923|00|100|0|75|Icepharma hf|Wyeth AB|Venlafaxín||13479||13479|18966 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|7248|10676|lyfalmen|||00|28|0|42|Icepharma hf|Wyeth AB|Venlafaxín||7248||7248|10676 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|594|1646|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||594||594|1646 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1278|2575|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|Hýdrókortisón og sýkingalyf||1278||1278|2575 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|3797|5993|lyfalmen|||00|28|0|21|Icepharma hf|Wyeth AB|Venlafaxín||3797||3797|5993 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|13057|18441|lyfalmen|V0955|16585|00|98|0|74|Icepharma hf|Wyeth AB|Venlafaxín||13057||13057|18441 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|24789|33047|lyfalmen|V0956|26249|00|98|0|147|Icepharma hf|Wyeth AB|Venlafaxín||24789||24789|33047 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|35672|46597|lyfalmen|V0956|26785|00|100|0|150|Icepharma hf|Wyeth AB|Venlafaxín||35672||35672|46597 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2188|3810|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough|Lóratadín||2188||2188|3810 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6606|9805|lyfalmen|V0984|3662|00|100|0|100|Vistor hf|Schering-Plough|Lóratadín||6606||6606|9805 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2468|4190|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2468||2468|4190 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10687|15343|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||10687||10687|15343 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2287 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1652|2365|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1652||1652|2365 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2607|3733|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2607||2607|3733 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|Díklófenak||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1614|3031|lyfalmen|V0221|3018|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||1614||1614|3031 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1320|2632|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|Blöndur||1320||1320|2632 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0|Aco Hud Nordic AB|ACO Hud AB|Permetrín||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|918|2086|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||918||918|2086 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|32683|42558|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zídóvúdín||32683||32683|42558 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|4089|6389|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|Glúkagon||4089||4089|6389 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|35378|46231|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||35378||35378|46231 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|50338|64538|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|Stavúdín||50338||50338|64538 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|51058|65435|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|Stavúdín||51058||51058|65435 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|3611|5741|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3611||3611|5741 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3183|5160|lyfalmen|||00|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3183||3183|5160 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|20251|27080|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||20251||20251|27080 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1878|3389|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1878||1878|3389 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|13659|6252|lyfalmen|V0411|5870|10|98|0|98|Icepharma hf|M.S.D.|Fínasteríð||3988||3988|6252 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1613|3183|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1613||1613|3183 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4508|6958|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4508||4508|6958 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1921|3447|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||1921||1921|3447 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12567|17831|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12567||12567|17831 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7168|10568|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||7168||7168|10568 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8781|12757|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||8781||8781|12757 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10544|15149|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10544||10544|15149 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|V0352|1798|00|100|0|25|Actavis Group hf|Actavis hf|Diltíazem||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|582|1630|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||582||582|1630 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1136|2382|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1136||1136|2382 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6496|9656|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||6496||6496|9656 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2629|4408|lyfalmen|V0712|2700|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|Baklófen||2629||2629|4408 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|598|1652|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|Atenólól||598||598|1652 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1284|2583|lyfalmen|||00|98|0|131|Actavis Group PTC ehf|Merck NM AB|Atenólól||1284||1284|2583 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|6184|8854|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||6184||6184|8854 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2233|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1196|1786|lyfalmen|V0902|1638|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||697||697|1786 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3770|5199|lyfalmen|V0903|4583|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3212||3212|5199 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6384|8637|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5745||5745|8637 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|21178|27618|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||20428||20428|27618 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|18504|25222|lyfalmen|V0552|10534|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||18504||18504|25222 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1295|2598|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Ketórólak||1295||1295|2598 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|61971|79339|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||61971||61971|79339 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|14227|19898|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|Imikvímóð||14227||14227|19898 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|3371|5415|lyfalmen|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||3371||3371|5415 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2851|4709|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |Oxýcódon||2851||2851|4709 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9382|13572|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |Oxýcódon||9382||9382|13572 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2767|4595|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||2767||2767|4595 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5385|8148|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |Oxýcódon||5385||5385|8148 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2845 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|17046|23407|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |Oxýcódon||17046||17046|23407 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|10846|15559|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |Oxýcódon||10846||10846|15559 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|29266|38621|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|Oxýcódon||29266||29266|38621 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|4028|5767|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||4028||4028|5767 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2564|4320|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2564||2564|4320 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|11330|8953|lyfalmen|||00|98|0|65|Icepharma hf|M.S.D.|Simvastatín||5978||5978|8953 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|17147|23533|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||17147||17147|23533 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|48549|62628|lyfalmen|V0375|42525|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||48549||48549|62628 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|19346|26271|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||19346||19346|26271 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|53489|68779|lyfalmen|V0376|47463|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||53489||53489|68779 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|57283|73185|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||57283||57283|73185 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1220|2407|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1220||1220|2407 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|937|2112|lyfalmen|||00|30|0|5|Vistor hf|Bayer HealthCare AG|Acarbósa||937||937|2112 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|3366|5408|lyfalmen|||00|120|0|20|Vistor hf|Bayer HealthCare AG|Acarbósa||3366||3366|5408 455428|B03XA0103|NeoRecormon|sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002|30.06.2009|R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|68777|87495|lyfsjukr|||00|3|0|30|Icepharma hf|Roche|Epóetín||68777||68777|87495 455527|B03XA0103|NeoRecormon|sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002|30.06.2009|R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|136749|172120|lyfsjukr|||00|3|0|60|Icepharma hf|Roche|Epóetín||136749||136749|172120 455576|B03XA0103|NeoRecormon|sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002|30.06.2009|R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|223750|280436|lyfsjukr|||00|5|0|10|Icepharma hf|Roche|Epóetín||223750||223750|280436 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|24466|32645|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||24466||24466|32645 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1113|2351|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group hf|Doxýcýklín||1113||1113|2351 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1213|2486|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis Group hf|Doxýcýklín||1213||1213|2486 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2659|4449|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis Group hf|Doxýcýklín||2659||2659|4449 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4502|6446|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4502||4502|6446 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4502|6446|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4502||4502|6446 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4915|7037|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4915||4915|7037 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4915|7037|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4915||4915|7037 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7358|10535|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7358||7358|10535 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7358|10535|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7358||7358|10535 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7358|10535|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7358||7358|10535 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|9211|13188|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||9211||9211|13188 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8979|12856|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8979||8979|12856 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11937|16729|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11937||11937|16729 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1081|2307|lyfalmen|||00|25|0|5|Vistor hf|Astra|Clómetíazól||1081||1081|2307 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1609|3024|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|Pívmecillínam||1609||1609|3024 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2339|4015|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|Pívmecillínam||2339||2339|4015 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9747|14068|lyfalmen|V0456|14068|00|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||9747||9747|14068 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12032|16847|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||12032||12032|16847 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12032|16847|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||12032||12032|16847 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|12032|16847|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||12032||12032|16847 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|14314|19688|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||14314||14314|19688 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1587|2272|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1587||1587|2272 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|95296|120511|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||95296||95296|120511 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1946|2786|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1946||1946|2786 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2253|3898|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2253||2253|3898 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2471|4194|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2471||2471|4194 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2456|4173|lyfalmen|||00|30|0|8|Vistor hf|Meda AS|Tranexamsýra||2456||2456|4173 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4995|7619|lyfalmen|||00|60|0|15|Vistor hf|Meda AS|Tranexamsýra||4995||4995|7619 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1122|2363|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1122||1122|2363 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4734|7265|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4734||4734|7265 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1679|3119|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||1679||1679|3119 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|3053|4983|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|Amoxicillín||3053||3053|4983 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|20204|27021|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||20204||20204|27021 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6773|10032|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||6773||6773|10032 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|80809|102475|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||80809||80809|102475 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|79809|101230|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||79809||79809|101230 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|198168|248587|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||198168||198168|248587 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|718|1815|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||718||718|1815 462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995|30.04.2009|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||2216||2216|3848 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|718|1815|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||718||718|1815 462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995|30.04.2009|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||2216||2216|3848 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7905|11568|lyfalmen|||56|7|0|7|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7905||7905|11568 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7481|14421|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7481||7481|14421 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5968|11539|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5968||5968|11539 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1975|3521|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Ovation Healthcare International Ltd.|Melperón||1975||1975|3521 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1325|2615|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1325||1325|2615 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1252|2471|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1252||1252|2471 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1342|2648|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1342||1342|2648 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|707|1395|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||707||707|1395 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|837|1976|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||837||837|1976 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2938|4827|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2938||2938|4827 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1781|3257|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1781||1781|3257 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|7149|10542|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||7149||7149|10542 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3425|5488|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||3425||3425|5488 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8833|12827|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8833||8833|12827 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5482|8280|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5482||5482|8280 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|5312|8049|lyfalmen|||64|100|0|50|Vistor hf|Meda AS|Móklóbemíð||5312||5312|8049 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|17705|23910|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||17705||17705|23910 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|27748|36414|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||27748||27748|36414 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|30044|39272|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|Interferón alfa-2b||30044||30044|39272 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|48938|62795|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|Interferón alfa-2b||48938||48938|62795 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|39845|51792|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|Sirolimus||39845||39845|51792 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|17233|23640|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||17233||17233|23640 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|100174|126584|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|Interferón alfa-2b||100174||100174|126584 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|32812|43036|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32812||32812|43036 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|769|1101|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|Halóperídól||769||769|1101 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7151|7130|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4635||4635|7130 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|448|641|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||448||448|641 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|12477|6783|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4379||4379|6783 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|26309|13901|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9624||9624|13901 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11342|16232|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||11342||11342|16232 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3239|5236|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|Tramadól||3239||3239|5236 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|13201|18620|lyfalmen|V0738|14810|00|100|0|67|Icepharma hf|Grunenthal|Tramadól||13201||13201|18620 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2532|4276|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|Tramadól||2532||2532|4276 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|10024|14443|lyfalmen|V0736|11450|00|100|0|50|Icepharma hf|Grunenthal|Tramadól||10024||10024|14443 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1721|3176|lyfalmen|V0733|2606|00|20|0|7|Icepharma hf|Grunenthal|Tramadól||1721||1721|3176 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6847|10132|lyfalmen|V0734|7753|00|100|0|33|Icepharma hf|Grunenthal|Tramadól||6847||6847|10132 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5794|8703|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5794||5794|8703 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6223||6223|8910 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||7625||7625|10917 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9018||9018|12912 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9600||9600|13745 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2221|3854|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||2221||2221|3854 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2608 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2364|4048|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2364||2364|4048 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5312|10290|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||5312||5312|10290 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2275|3928|lyfalmen|V2003|3867|43|98|0|31|Vistor hf|AstraZeneca A/S DK|Metóprólól||2275||2275|3928 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2683|4481|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2683||2683|4481 473348|A03AA0402|Spasmerin|töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|957|2139|lyfalmen|||00|50|0|22|Actavis Group hf|Actavis hf|Mebeverín||957||957|2139 473371|A03AA0402|Spasmerin|töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1680|3120|lyfalmen|||00|100|0|45|Actavis Group hf|Actavis hf|Mebeverín||1680||1680|3120 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|14268|19631|lyfsjukr|||00|400|0|0|Vistor hf|Meda AB|Dextran||14268||14268|19631 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1023|2229|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1023||1023|2229 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|46492|59750|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Nevírapín||46492||46492|59750 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2065|3643|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|Mómetasón||2065||2065|3643 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|1|Actavis Group hf|Actavis Group hf|Paracetamól||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|Warfarín||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4164|6491|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|Estradíól||4164||4164|6491 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|229|1151|lyfalmen|V0775|1151|00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||229||229|1151 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|318|1272|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||318||318|1272 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|890|2048|lyfalmen|V0780|2048|00|100|0|33|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||890||890|2048 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|6960|10285|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl||6960||6960|10285 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3404|5460|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|Formóteról||3404||3404|5460 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|4554|7020|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|Formóteról||4554||4554|7020 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|13346|18801|lyfalmen|||00|98|0|196|Icepharma hf|Roche|Cílazapríl||13346||13346|18801 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6221|9283|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||6221||6221|9283 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5283|8010|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5283||5283|8010 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1238|2520|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1238||1238|2520 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6944|10264|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6944||6944|10264 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|10553|15161|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10553||10553|15161 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4861|7437|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4861||4861|7437 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|10189|14667|lyfalmen|||00|98|0|131|Vistor hf|Meda AS|Benazepríl||10189||10189|14667 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|21859|29399|lyfalmen|||00|98|0|261|Vistor hf|Meda AS|Benazepríl||21859||21859|29399 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4714|7238|lyfalmen|||00|28|0|28|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4714||4714|7238 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|12206|17381|lyfalmen|||00|84|0|84|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12206||12206|17381 481168|N06AX1201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|8140|11887|lyfalmen|||00|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||||8140|11887 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|12563|17826|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||12563||12563|17826 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|44192|56887|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Clostridium botulinum toxín-A||44192||44192|56887 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|69265|88420|lyfalmen|V0557|33109|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||69265||69265|88420 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4016|5750|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4016||4016|5750 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|6086|8714|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||6086||6086|8714 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|91828|116193|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|Triptórelín||91828||91828|116193 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|7460|10964|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Fínasteríð||7460||7460|10964 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1344|2664|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|Benzýdamín||1344||1344|2664 484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004|30.04.2009|R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||543||543|777 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|708|1801|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||708||708|1801 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|697|1786|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||697||697|1786 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2777|4609|lyfalmen|||00|30|0|15|Icepharma hf|Servier|Perindópríl||2777||2777|4609 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|4053|6340|lyfalmen|||00|30|0|30|Icepharma hf|Servier|Perindópríl||4053||4053|6340 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|815|1946|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|Nítrófúrantóín||815||815|1946 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|877|2031|lyfalmen|||00|20|0|10|Vistor hf|Meda AB|Nabúmeton||877||877|2031 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2610|4382|lyfalmen|||00|60|0|30|Vistor hf|Meda AB|Nabúmeton||2610||2610|4382 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|10864|15583|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||10864||10864|15583 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|19610|26599|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||19610||19610|26599 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|960|1474|lyfalmen|V0609|1424|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2453|4169|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2453||2453|4169 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2875|4742|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2875||2875|4742 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9571|13829|lyfalmen|||00|5|0|2|Icepharma hf|Roche as|Granisetrón||9571||9571|13829 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5266|7987|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||5266||5266|7987 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12080|11470|lyfalmen|V0337|6756|00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||7833||7833|11470 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|8172|11930|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||8172||8172|11930 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|17143|15635|lyfalmen|V0338|9234|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||10902||10902|15635 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12685|17978|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12685||12685|17978 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|21803|19307|lyfalmen|V0339|11516|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||13753||13753|19307 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|24595|32806|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|Rívastigmín||24595||24595|32806 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|54008|69107|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|BCG bóluefni||54008||54008|69107 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3787|5980|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3787||3787|5980 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11587|16565|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Ómeprazól||11587||11587|16565 492546|A02BC0102 |Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1443|2799|lyfalmen|V1140|2593|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Míanserín||1443||1443|2799 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4779|7326|lyfalmen|||00|28|0|19|Vistor hf|Bristol-Myers Squibb|Pravastatín||4779||4779|7326 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1628|3050|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1628||1628|3050 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4382|6787|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Pízótífen||4382||4382|6787 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|97486|123238|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||97486||97486|123238 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|243717|305295|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||243717||243717|305295 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2531|4275|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2531||2531|4275 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2887|4758|lyfalmen|V0408|2195|23|84|0|84|Vistor hf|Novo-Nordisk|Estradíól||2887||2887|4758 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3662|5810|lyfalmen|V0388|4430|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3662||3662|5810 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3527|5627|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||3527||3527|5627 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|19948|27020|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||19948||19948|27020 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7759|11370|lyfalmen|V1088|7729|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7759||7759|11370 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11085|15883|lyfalmen|V1089|12111|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||11085||11085|15883 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002|30.06.2009|R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18457|25164|lyfalmen|||00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||18457||18457|25164 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002|30.06.2009|R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|31112|40919|lyfalmen|||00|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||31112||31112|40919 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|3044|4971|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||3044||3044|4971 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4714|9151|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||4714|9151 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4396|6806|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4396||4396|6806 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1110|2347|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1110||1110|2347 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3483|5567|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3483||3483|5567 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|622|1684|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||622||622|1684 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|945|2123|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||945||945|2123 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3601|5727|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3601||3601|5727 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Enalapríl||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|00|100|0|50|Actavis Group hf|Actavis hf|Enalapríl||802||802|1929 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|00|100|0|200|Actavis Group hf|Actavis hf|Enalapríl||2725||2725|4538 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|Klórhexidín||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|811|1941|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||811||811|1941 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1518|2900|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|Betametasón||1518||1518|2900 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|20429|27619|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||20429||20429|27619 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|22024|29605|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||22024||22024|29605 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|29801|39287|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||29801||29801|39287 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|34246|44821|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||34246||34246|44821 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|811|1941|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||811||811|1941 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3952|6203|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3952||3952|6203 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2349|4028|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2349||2349|4028 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3329|5358|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|Maprótilín||3329||3329|5358 502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986|30.04.2009|R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|3977|6237|lyfalmen|||00|100|0|53|Vistor hf|Schering-Plough|Perfenazín||3977||3977|6237 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|34452|44760|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|Triptórelín||34452||34452|44760 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2270|3921|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2270||2270|3921 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2478|4203|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|Estríól||2478||2478|4203 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977|31.05.2009|R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1324|2637|lyfalmen|||10|50|0|50|Vistor hf|Schering-Plough|Dexklórfeníramín||1324||1324|2637 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007|31.05.2009|R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|617|1678|lyfalmen|||00|50|0|0|Vistor hf|Schering-Plough|Dexklórfeníramín||617||617|1678 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1425|2774|lyfalmen|||00|100|0|30|Icepharma hf|Roche|Brómazepam||1425||1425|2774 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|9158|13268|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|Maprótilín||9158||9158|13268 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3686|5277|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||3686||3686|5277 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|7176|10274|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||7176||7176|10274 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|12733|17720|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||12733||12733|17720 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|3485|4990|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|Gentamícín||3485||3485|4990 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|32312|42096|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Ísóflúran||32312||32312|42096 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2732|4548|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||2732||2732|4548 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12|Vistor hf|Orion Pharma|Bisakódýl||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|446|1446|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|Bisakódýl||446||446|1446 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1272 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5406 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|10139|17546|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||10139||10139|17546 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|IBV|0|0|0|100|DKK|2804|5512|vetalmen|||27|50|0|0|Vistor hf|Intervet International BV|||2804||2804|5512 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2852|4711|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|Verapamíl||2852||2852|4711 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5700|11029|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||||5700|11029 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4571|8878|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||4571||4571|8878 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|14142|27110|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||14142||14142|27110 508952|G03FB0902|Nuvelle|töflur|0| |84|stk|1|þpakki||G03FB09|01.08.1997|30.04.2009|R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2623|4400|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||2623||2623|4400 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|11133|15948|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11133||11133|15948 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon|Estríól|||||2877 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|458|1462|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||458||458|1462 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|516|1541|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||516||516|1541 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|378|1353|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||378||378|1353 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|458|1462|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||458||458|1462 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|51594|66102|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín og lamívúdín||51594||51594|66102 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|14658|20117|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|Epóetín||14658||14658|20117 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|26667|35068|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|Epóetín||26667||26667|35068 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|34224|44476|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|Epóetín||34224||34224|44476 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|56148|71772|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|Epóetín||56148||56148|71772 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|108795|137317|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|Epóetín||108795||108795|137317 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|274158|343194|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|Epóetín||274158||274158|343194 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4646|5870|lyfalmen|V0411|5870|00|98|0|98|Actavis Group hf|Actavis hf|Fínasteríð||3706||3706|5870 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3180|5156|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |||3180||3180|5156 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3003|4916|lyfalmen|V0385|4815|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3003||3003|4916 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|21464|28590|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||21464||21464|28590 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|13427|18584|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||13427||13427|18584 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|10607|15073|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||10607||10607|15073 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|2015|3575|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Terbútalín||2015||2015|3575 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2341|4017|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2341||2341|4017 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5617|8463|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5617||5617|8463 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|1854|3356|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||1854||1854|3356 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4397|6807|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|Repaglíníð||4397||4397|6807 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|5161|7844|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|Repaglíníð||5161||5161|7844 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|6348|9455|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|Repaglíníð||6348||6348|9455 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1023|2229|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|Díklófenak||1023||1023|2229 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|4866|7444|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|Díklófenak||4866||4866|7444 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2325|3996|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|Desógestrel||2325||2325|3996 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1017|2220|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1017||1017|2220 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|9229|13365|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||9229||9229|13365 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5368|8125|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5368||5368|8125 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6063|9068|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6063||6063|9068 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|18385|25074|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||18385||18385|25074 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6507|9671|lyfalmen|V1300|9264|00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6507||6507|9671 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17991|24584|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||17991||17991|24584 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1623|3043|lyfalmen|V0308|3043|00|100|0|100|Actavis Group hf|Actavis hf|Amlódipín||1623||1623|3043 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2644|4428|lyfalmen|V0310|4428|00|100|0|200|Actavis Group hf|Actavis hf|Amlódipín||2644||2644|4428 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|410|1397|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||410||410|1397 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|37677|49093|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|Pramipexól||37677||37677|49093 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8910|17143|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8910||8910|17143 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3705|5868|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3705||3705|5868 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|296284|370741|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|Basiliximab||296284||296284|370741 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|448|1448|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||448||448|1448 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1851|3352|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||1851||1851|3352 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|10859|15577|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||10859||10859|15577 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|960|2143|lyfalmen|V0732|2143|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||960||960|2143 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9913|14293|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||9913||9913|14293 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|407|1393|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||407||407|1393 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1253 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1240|2523|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1240||1240|2523 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|26615|35321|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|Flútamíð||26615||26615|35321 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1031|2239|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1031||1031|2239 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2621|4397|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2621||2621|4397 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1158 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1136 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1125|2367|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1125||1125|2367 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1127|2370|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1127||1127|2370 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|12283|17477|lyfalmen|||00|30|0|10|Vistor hf|Cephalon France (V)|Modafinil||12283||12283|17477 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|8133|11877|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||8133||8133|11877 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|5126|7797|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5126||5126|7797 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|IBV|0|0|0|100|DKK|7431|14326|vetalmen|||16|188|0|0|Vistor hf|Intervet International BV|||7431||7431|14326 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4547|7011|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4547||4547|7011 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|14889|20404|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||14889||14889|20404 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1290|2591|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Emedastín||1290||1290|2591 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2139|3063|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|Búprenorfín||2139||2139|3063 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4768|9254|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4768||4768|9254 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4107|7994|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4107||4107|7994 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5469|7830|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|Búprenorfín||5469||5469|7830 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|89124|112827|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Fosfenýtóín||89124||89124|112827 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|10728|15224|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||10728||10728|15224 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|29091|38086|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||29091||29091|38086 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|58182|74304|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||58182||58182|74304 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3849|6064|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3849||3849|6064 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2744|4564|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||2744||2744|4564 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|10102|14444|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |Nevírapín||10102||10102|14444 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|349|1314|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||349||349|1314 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1853|3355|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|Terbútalín||1853||1853|3355 534537|J01EE0103|Primazol|töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1486|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||476||476|1486 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|Bioglan Pharma AB|Dísúlfíram í blöndum||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6270|9349|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6270||6270|9349 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|455|1458|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||455||455|1458 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|580|1627|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||580||580|1627 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|15804|21861|lyfalmen|||52|100|0|12|Vistor hf|Meda AS|Brómókriptín||15804||15804|21861 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||699 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon|Estríól|||||2423 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|5|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|10|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|138281|174027|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|Interferón beta-1a||138281||138281|174027 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10386|14935|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10386||10386|14935 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|195|1105|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|Díazepam||195||195|1105 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|425|1417|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|Díazepam||425||425|1417 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2836|4689|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2836||2836|4689 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|3108|5058|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||3108||3108|5058 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|8704|12652|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||8704||8704|12652 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1962|3503|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||1962||1962|3503 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|10601|15226|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||10601||10601|15226 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|17171|23563|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||17171||17171|23563 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1668|3104|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|Verapamíl||1668||1668|3104 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4907|7499|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Pindólól||4907||4907|7499 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Actavis Group hf|Actavis hf|Dífenhýdramín í blöndum||||| 543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|23337|30922|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||23337||23337|30922 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|22|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|9|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|46246|59444|lyfsjukr|||00|1|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||46246||46246|59444 543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|91867|116242|lyfsjukr|||00|1|0|2|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||91867||91867|116242 543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|167031|209821|lyfsjukr|||00|1|0|4|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||167031||167031|209821 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|25589|34043|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|Follitrópín alfa||25589||25589|34043 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|789|1911|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||789||789|1911 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1327|2641|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1327||1327|2641 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3527|5627|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3527||3527|5627 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|33695|44135|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||33695||33695|44135 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|27166|36007|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||27166||27166|36007 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|33893|44382|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||33893||33893|44382 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|28794|38034|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||28794||28794|38034 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|DKK|9208|13336|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||9208||9208|13336 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyflausa|||23|60|0|15|Vistor hf|Orion Corporation|Súkralfat||||| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|11018|15585|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||11018||11018|15585 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3631|5199|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3631||3631|5199 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9556|13808|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||9556||9556|13808 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|59414|76155|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|Follitrópín beta||59414||59414|76155 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4908|7501|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|Follitrópín beta||4908||4908|7501 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|23890|31928|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|Follitrópín beta||23890||23890|31928 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|19165|26045|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|Sibutramin||19165||19165|26045 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|19165|26045|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|Sibutramin||19165||19165|26045 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2340|3350|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2340||2340|3350 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5868|8804|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||5868||5868|8804 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|16017|22126|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||16017||16017|22126 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|41057|53301|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||41057||41057|53301 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|115649|145851|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||115649||115649|145851 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|8730|12687|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|Halóperídól||8730||8730|12687 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|165817|208310|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||165817||165817|208310 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2300|3962|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefna­vakar||2300||2300|3962 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|10097|14543|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||10097||10097|14543 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1682|3123|lyfalmen|||03|1|0|3|Vistor hf|Meda AB|Tríamcínólón||1682||1682|3123 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3836|6046|lyfalmen|||00|100|0|50|Vistor hf|Meda AB|Nabúmeton||3836||3836|6046 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|Morfín||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2417|1904|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|Rabeprazól||784||784|1904 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|3808|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|Rabeprazól||2187||2187|3808 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2503|4237|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|Rabeprazól||2503||2503|4237 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|Rabeprazól||928||928|2100 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7916|3975|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|Rabeprazól||2310||2310|3975 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3956|6209|lyfalmen|||63|100|0|67|Vistor hf|Bayer HealthCare AG|Nífedipín||3956||3956|6209 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|669|1748|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|Díklófenak||669||669|1748 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|4630|7124|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|Zópíklón||4630||4630|7124 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3895|6126|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3895||3895|6126 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3867|6088|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3867||3867|6088 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2655|4443|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||2655||2655|4443 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4576|7050|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||4576||4576|7050 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|8078|15559|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8078||8078|15559 555607|N06AB0601|Zoloft|mixtúruþ|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5443|8227|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||5443||5443|8227 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3520|5040|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Elektrólýtar||3520||3520|5040 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6772|9696|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||6772||6772|9696 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5742|8221|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5742||5742|8221 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4230|6056|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||4230||4230|6056 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3933|5631|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||3933||3933|5631 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5435|8216|lyfalmen|V2150|8215|00|100|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5435||5435|8216 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7499|11017|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7499||7499|11017 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|10596|15220|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||10596||10596|15220 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1779|3255|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1779||1779|3255 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|167802|210781|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|Gadópentetat||167802||167802|210781 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1091|2321|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|Verapamíl||1091||1091|2321 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2166|3780|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|Verapamíl||2166||2166|3780 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1166|2423|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|Tramadól||1166||1166|2423 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|654|1728|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|Tramadól||654||654|1728 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1824|3316|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|Tramadól||1824||1824|3316 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1049|2264|lyfalmen|V0732|2143|02|10|0|2|Icepharma hf|Grunenthal|Tramadól||1049||1049|2264 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2702|4507|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2702||2702|4507 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6381|9500|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estradíól||6381||6381|9500 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2910|4789|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2910||2910|4789 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3214|5202|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3214||3214|5202 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|11062|15640|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|Desflúran||11062||11062|15640 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1330 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3282|5294|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3282||3282|5294 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994|30.06.2009|R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|12083|17228|lyfalmen|||00|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||12083||12083|17228 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1872|3381|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1872||1872|3381 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6256|9330|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6256||6256|9330 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6784|10047|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6784||6784|10047 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|120679|152113|lyfsjukr|||00|5|0|1|Vistor hf|Abbott Scandinavia AB|Levosimendan||120679||120679|152113 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|636062|597261|lyfsjukr|||00|20|0|5|Vistor hf|Abbott Scandinavia AB|Levosimendan||478228||478228|597261 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2708|4515|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2708||2708|4515 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|37128|48409|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|Mirtazapín||37128||37128|48409 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|27746|36729|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||27746||27746|36729 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|42713|55363|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||42713||42713|55363 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|730|1831|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||730||730|1831 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2266|3915|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2266||2266|3915 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|730|1831|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||730||730|1831 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2266|3915|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2266||2266|3915 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1806|3291|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1806||1806|3291 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|229454|287855|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||229454||229454|287855 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5288|8016|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5288||5288|8016 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5570|8399|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5570||5570|8399 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9843|14198|lyfalmen|||00|98|0|33|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||9843||9843|14198 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12463|17701|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||12463||12463|17701 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|169211|212535|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|Ribavirin||169211||169211|212535 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6003|8987|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||6003||6003|8987 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|9009|13066|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||9009||9009|13066 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1593|3002|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1593||1593|3002 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|12875|18214|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Olsalazín||12875||12875|18214 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1441|2796|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|Brinzólamíð||1441||1441|2796 566661|L04AB0101|Enbrel|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|86735|109853|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||86735||86735|109853 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6444|9585|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||6444||6444|9585 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1618|3036|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1618||1618|3036 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8573|12474|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||||8573|12474 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6788|10052|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||6788||6788|10052 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6264|9341|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|Risperídón||6264||6264|9341 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13791|19355|lyfalmen|V0793|8270|00|60|0|24|Vistor hf|Janssen-Cilag AB|Risperídón||13791||13791|19355 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|22922|30723|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|Risperídón||22922||22922|30723 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|30372|39998|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|Risperídón||30372||30372|39998 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 567636|N05BA1205|Alprazolam Mylan|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|A||0|0|0|0|RAN|0|0|0|100|SEK|1061|2280|lyfalmen|V0857|2131|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Alprazólam||||1061|2280 567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998|30.04.2009|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|18936|25760|lyfalmen|||00|98|0|131|Vistor hf|Bristol-Myers Squibb|Pravastatín||18936||18936|25760 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||14023||14023|19326 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5568||5568|7972 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|8520|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|Rabeprazól||5659||5659|8520 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|2245|3887|lyfalmen|V2072|3542|00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||2245||2245|3887 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1173|2432|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1173||1173|2432 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|Felódipín||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|19824|26548|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||19824||19824|26548 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|19824|26548|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||19824||19824|26548 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2561|4316|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2561||2561|4316 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3647|5790|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3647||3647|5790 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|137019|172456|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|Fíbrínógen manna||137019||137019|172456 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|179349|225157|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|Fíbrínógen manna||179349||179349|225157 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|337401|421932|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|Fíbrínógen manna||337401||337401|421932 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3726|5897|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|Estradíól||3726||3726|5897 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|113859|143622|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|Trastuzumab||113859||113859|143622 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|29042|38025|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|Meropenem||29042||29042|38025 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|56841|72635|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|Meropenem||56841||56841|72635 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|4009|3693|lyfalmen|V0931|2428|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||2102||2102|3693 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|13260|10155|lyfalmen|V0933|6361|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||6864||6864|10155 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|6875|5624|lyfalmen|V0935|3559|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||3525||3525|5624 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|21629|16585|lyfalmen|V0937|10351|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||11602||11602|16585 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0|Icepharma hf|Norpharma |Malatíón||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|6258|8960|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|Adenósín||6258||6258|8960 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|105651|133403|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|Infliximab||105651||105651|133403 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996|30.06.2009|R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|6854|10142|lyfalmen|||00|28|0|14|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||6854||6854|10142 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3096|5042|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||3096||3096|5042 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1205|2476|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|Terbútalín||1205||1205|2476 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|879|2033|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|Metótrexat||879||879|2033 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|34202|44449|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||34202||34202|44449 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|68095|86646|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||68095||68095|86646 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|130502|164342|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||130502||130502|164342 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5536|9580|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||5536||5536|9580 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|20862|36103|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||20862||20862|36103 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||39554||39554|51112 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||70812||70812|90028 582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001|30.04.2009|R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|425|1417|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Metóprólól||425||425|1417 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|751|1860|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|Metóprólól||751||751|1860 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||53298||53298|68224 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1093|2324|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Sótalól||1093||1093|2324 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||82356||82356|104401 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||61388||61388|78296 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||92841||92841|117455 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4238|6068|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Elektrólýtar||4238||4238|6068 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2207|3160|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2207||2207|3160 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|8150|11669|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||8150||8150|11669 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6686|9573|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Kolvetni||6686||6686|9573 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3248|4650|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3248||3248|4650 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9283|13291|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Kolvetni||9283||9283|13291 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3673|5259|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3673||3673|5259 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4378|6268|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4378||4378|6268 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2475|3544|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2475||2475|3544 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0|Icepharma hf|Fresenius Kabi|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|3762|5946|lyfalmen|||64|30|0|30|Vistor hf|Meda AS|Móklóbemíð||3762||3762|5946 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|11082|15665|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|Heparín||11082||11082|15665 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|4037|5780|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|Heparín||4037||4037|5780 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|39650|51232|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|Imipenem og ensímhemill||39650||39650|51232 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3895|6126|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3895||3895|6126 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|38434|50035|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||38434||38434|50035 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2922|4806|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2922||2922|4806 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3440|4925|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3440||3440|4925 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1505|2883|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1505||1505|2883 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2437|4148|lyfalmen|V0426|4080|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2437||2437|4148 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|13279|18717|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||13279||13279|18717 588723|B03AA0702|Ferlen-R|forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|60|0|30|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9755|14078|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9755||9755|14078 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6762|11702|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||6762||6762|11702 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2621|4536|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2621||2621|4536 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6524|11290|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||6524||6524|11290 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3524|6098|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3524||3524|6098 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3660|6334|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3660||3660|6334 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2835|4906|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2835||2835|4906 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|151309|190247|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||151309||151309|190247 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|95377|120612|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|Ritonavír||95377||95377|120612 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|20|Vistor hf|Bayer A/S|Klótrímazól||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Ýmis lyf||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|29455|38856|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||29455||29455|38856 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|217216|272301|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|Tenekteplasi||217216||217216|272301 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||31979||31979|41681 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||36833||36833|47725 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3614|5174|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||3614||3614|5174 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|6965|10292|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|Kalcítríól||6965||6965|10292 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|720|1817|lyfalmen|||00|50|0|3|Icepharma hf|Roche|Klónazepam||720||720|1817 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1124|2366|lyfalmen|||00|150|0|9|Icepharma hf|Roche|Klónazepam||1124||1124|2366 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1910|3432|lyfalmen|||00|100|0|25|Icepharma hf|Roche|Klónazepam||1910||1910|3432 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|19721|26738|lyfalmen|||03|12|0|32|Vistor hf|Meda AB|Tríamcínólón||19721||19721|26738 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||651 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5406 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3171|4540|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3171||3171|4540 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1138|2246|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1138||1138|2246 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|9678|13856|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9678||9678|13856 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|664|1741|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||664||664|1741 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4318|6700|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||4318||4318|6700 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991|30.06.2009|L|A|5|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1002|2200|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||1002||1002|2200 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1218|2493|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1218||1218|2493 908048|J07AM5201|Immunoglob. mot tetanus|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|9865|14228|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||9865||9865|14228 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4276|6643|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4276||4276|6643 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2314||2314|3981 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|USD|3266|4676|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3266||3266|4676 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2064|2955|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||2064||2064|2955 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12013|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||8233||8233|12013 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3242|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||1770||1770|3242 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|4996|7620|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||4996||4996|7620 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6365|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||4071||4071|6365 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|10884|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||7401||7401|10884 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|11596|16577|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||11596||11596|16577 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Distica|Distica - óskráð lyf|Estradíól||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Distica|Distica - óskráð lyf|Estradíól||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Distica|Distica - óskráð lyf|Estradíól||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Distica|Distica - óskráð lyf|Testósterón||1837||1837|3333 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Distica|Distica - óskráð lyf|Testósterón||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||10030||10030|14355 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1533|2921|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1533||1533|2921 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|3952|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|3952 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3625|5760|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3625||3625|5760 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3651|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3651 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1307||1307|1871 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|755|1865|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||755||755|1865 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4952|7090|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||4952||4952|7090 952251|J01CA0101|Ampicillin|sts|0| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|Morfín||3127||3127|5084 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1410|2754|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1410||1410|2754 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|848|1991|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||848||848|1991 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|16941|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|16941 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|12918|17950|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||12918||12918|17950 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2108|3701|lyfalmen|||00|20|1|20|Parlogis hf|Parlogis - óskráð lyf|||||2108|3701 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4400|6811|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||4400||4400|6811 962523|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|10|fl||B05BB01|01.05.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|5430|7774|lyfsjukr|||0|1000|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||5430||5430|7774